<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Respiratory muscle training in children and adults with neuromuscular disease - Silva, IS - 2019 | Cochrane Library</title> <meta content="Respiratory muscle training in children and adults with neuromuscular disease - Silva, IS - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011711.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Respiratory muscle training in children and adults with neuromuscular disease - Silva, IS - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011711.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011711.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Respiratory muscle training in children and adults with neuromuscular disease" name="citation_title"/> <meta content="Ivanizia S Silva" name="citation_author"/> <meta content="Federal University of Rio Grande do Norte" name="citation_author_institution"/> <meta content="iziasoares@gmail.com" name="citation_author_email"/> <meta content="Rafaela Pedrosa" name="citation_author"/> <meta content="Federal University of Paraiba" name="citation_author_institution"/> <meta content="Ingrid G Azevedo" name="citation_author"/> <meta content="Anne‐Marie Forbes" name="citation_author"/> <meta content="University of Tasmania" name="citation_author_institution"/> <meta content="Guilherme AF Fregonezi" name="citation_author"/> <meta content="Mário ET Dourado Junior" name="citation_author"/> <meta content="Federal University of Rio Grande do Norte" name="citation_author_institution"/> <meta content="Suzianne RH Lima" name="citation_author"/> <meta content="Federal University of Rio Grande do Norte" name="citation_author_institution"/> <meta content="Gardenia MH Ferreira" name="citation_author"/> <meta content="Federal University of Rio Grande do Norte" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD011711.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/09/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011711.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011711.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011711.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Breathing Exercises [*methods]; Exhalation [physiology]; Muscle Weakness; Neuromuscular Diseases [*rehabilitation]; Quality of Life; Randomized Controlled Trials as Topic; Vital Capacity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011711.pub2&amp;doi=10.1002/14651858.CD011711.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="77cjsSG8";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011711\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011711\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ms","fa","de","zh_HANS","ru","fr","ja","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011711.pub2",title:"Respiratory muscle training in children and adults with neuromuscular disease",firstPublishedDate:"Sep 5, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neuromuscular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011711.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011711.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011711.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011711.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011711.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011711.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011711.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011711.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011711.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011711.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>15296 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011711.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-sec-0150"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-sec-0069"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-sec-0138"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/appendices#CD011711-sec-0155"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/table_n/CD011711StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/table_n/CD011711StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Respiratory muscle training in children and adults with neuromuscular disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#CD011711-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Ivanizia S Silva</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#CD011711-cr-0003">Rafaela Pedrosa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#CD011711-cr-0004">Ingrid G Azevedo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#CD011711-cr-0005">Anne‐Marie Forbes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#CD011711-cr-0006">Guilherme AF Fregonezi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#CD011711-cr-0007">Mário ET Dourado Junior</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#CD011711-cr-0008">Suzianne RH Lima</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information#CD011711-cr-0009">Gardenia MH Ferreira</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information/en#CD011711-sec-0162">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 September 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011711.pub2">https://doi.org/10.1002/14651858.CD011711.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011711-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011711-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011711-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011711-abs-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011711-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011711-abs-0010">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011711-abs-0001" lang="en"> <section id="CD011711-sec-0001"> <h3 class="title" id="CD011711-sec-0001">Background</h3> <p>Neuromuscular diseases (NMDs) are a heterogeneous group of diseases affecting the anterior horn cell of spinal cord, neuromuscular junction, peripheral nerves and muscles. NMDs cause physical disability usually due to progressive loss of strength in limb muscles, and some NMDs also cause respiratory muscle weakness. Respiratory muscle training (RMT) might be expected to improve respiratory muscle weakness; however, the effects of RMT are still uncertain. This systematic review will synthesize the available trial evidence on the effectiveness and safety of RMT in people with NMD, to inform clinical practice. </p> </section> <section id="CD011711-sec-0002"> <h3 class="title" id="CD011711-sec-0002">Objectives</h3> <p>To assess the effects of respiratory muscle training (RMT) for neuromuscular disease (NMD) in adults and children, in comparison to sham training, no training, standard treatment, breathing exercises, or other intensities or types of RMT. </p> </section> <section id="CD011711-sec-0003"> <h3 class="title" id="CD011711-sec-0003">Search methods</h3> <p>On 19 November 2018, we searched the Cochrane Neuromuscular Specialized Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, and Embase. On 23 December 2018, we searched the US National Institutes for Health Clinical Trials Registry (ClinicalTrials.gov), the World Health Organization International Clinical Trials Registry Platform, and reference lists of the included studies. </p> </section> <section id="CD011711-sec-0004"> <h3 class="title" id="CD011711-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) and quasi‐RCTs, including cross‐over trials, of RMT in adults and children with a diagnosis of NMD of any degree of severity, who were living in the community, and who did not need mechanical ventilation. We compared trials of RMT (inspiratory muscle training (IMT) or expiratory muscle training (EMT), or both), with sham training, no training, standard treatment, different intensities of RMT, different types of RMT, or breathing exercises. </p> </section> <section id="CD011711-sec-0005"> <h3 class="title" id="CD011711-sec-0005">Data collection and analysis</h3> <p>We followed standard Cochrane methodological procedures.</p> </section> <section id="CD011711-sec-0006"> <h3 class="title" id="CD011711-sec-0006">Main results</h3> <p>We included 11 studies involving 250 randomized participants with NMDs: three trials (N = 88) in people with amyotrophic lateral sclerosis (ALS; motor neuron disease), six trials (N = 112) in Duchenne muscular dystrophy (DMD), one trial (N = 23) in people with Becker muscular dystrophy (BMD) or limb‐girdle muscular dystrophy, and one trial (N = 27) in people with myasthenia gravis. </p> <p>Nine of the trials were at high risk of bias in at least one domain and many reported insufficient information for accurate assessment of the risk of bias. Populations, interventions, control interventions, and outcome measures were often different, which largely ruled out meta‐analysis. All included studies assessed lung capacity, our primary outcome, but four did not provide data for analysis (1 in people with ALS and three cross‐over studies in DMD). None provided long‐term data (over a year) and only one trial, in ALS, provided information on adverse events. Unscheduled hospitalisations for chest infection or acute exacerbation of chronic respiratory failure were not reported and physical function and quality of life were reported in one (ALS) trial. </p> <p><b>Amyotrophic lateral sclerosis (ALS)</b> </p> <p>Three trials compared RMT versus sham training in ALS. Short‐term (8 weeks) effects of RMT on lung capacity in ALS showed no clear difference in the change of the per cent predicted forced vital capacity (FVC%) between EMT and sham EMT groups (mean difference (MD) 0.70, 95% confidence interval (CI) ‐8.48 to 9.88; N = 46; low‐certainty evidence). The mean difference (MD) in FVC% after four months' treatment was 10.86% in favour of IMT (95% CI ‐4.25 to 25.97; 1 trial, N = 24; low‐certainty evidence), which is larger than the minimal clinically important difference (MCID, as estimated in people with idiopathic pulmonary fibrosis). There was no clear difference between IMT and sham IMT groups, measured on the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALFRS; range of possible scores 0 = best to 40 = worst) (MD 0.85, 95% CI ‐2.16 to 3.85; 1 trial, N = 24; low‐certainty evidence) or quality of life, measured on the EuroQol‐5D (0 = worst to 100 = best) (MD 0.77, 95% CI ‐17.09 to 18.62; 1 trial, N = 24; low‐certainty evidence) over the medium term (4 months). One trial report stated that the IMT protocol had no adverse effect (very low‐certainty evidence). </p> <p><b>Duchenne muscular dystrophy (DMD)</b> </p> <p>Two DMD trials compared RMT versus sham training in young males with DMD. In one study, the mean post‐intervention (6‐week) total lung capacity (TLC) favoured RMT (MD 0.45 L, 95% CI ‐0.24 to 1.14; 1 trial, N = 16; low‐certainty evidence). In the other trial there was no clear difference in post‐intervention (18 days) FVC between RMT and sham RMT (MD 0.16 L, 95% CI ‐0.31 to 0.63; 1 trial, N = 20; low‐certainty evidence). One RCT and three cross‐over trials compared a form of RMT with no training in males with DMD; the cross‐over trials did not provide suitable data. Post‐intervention (6‐month) values showed no clear difference between the RMT and no training groups in per cent predicted vital capacity (VC%) (MD 3.50, 95% CI ‐14.35 to 21.35; 1 trial, N = 30; low‐certainty evidence). </p> <p><b>Becker or limb‐girdle muscular dystrophy</b> </p> <p>One RCT (N = 21) compared 12 weeks of IMT with breathing exercises in people with Becker or limb‐girdle muscular dystrophy. The evidence was of very low certainty and conclusions could not be drawn. </p> <p><b>Myasthenia gravis</b> </p> <p>In myasthenia gravis, there may be no clear difference between RMT and breathing exercises on measures of lung capacity, in the short term (TLC MD ‐0.20 L, 95% CI ‐1.07 to 0.67; 1 trial, N = 27; low‐certainty evidence). Effects of RMT on quality of life are uncertain (1 trial; N = 27). </p> <p>Some trials reported effects of RMT on inspiratory and/or expiratory muscle strength; this evidence was also of low or very low certainty. </p> </section> <section id="CD011711-sec-0007"> <h3 class="title" id="CD011711-sec-0007">Authors' conclusions</h3> <p>RMT may improve lung capacity and respiratory muscle strength in some NMDs. In ALS there may not be any clinically meaningful effect of RMT on physical functioning or quality of life and it is uncertain whether it causes adverse effects. Due to clinical heterogeneity between the trials and the small number of participants included in the analysis, together with the risk of bias, these results must be interpreted very cautiously. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011711-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011711-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011711-abs-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011711-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011711-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011711-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011711-abs-0015">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011711-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011711-abs-0016">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011711-abs-0012">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011711-abs-0011">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011711-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011711-abs-0004" lang="en"> <h3>Respiratory muscle training in children and adults with neuromuscular disease</h3> <p><b>Review question</b> </p> <p>Does respiratory muscle training have beneficial effects for children and adults with neuromuscular disease? </p> <p><b>Background</b> </p> <p>Neuromuscular disease is a very broad term that covers many diseases that either directly or indirectly affect muscles or nerves. Children and adults with neuromuscular diseases can present with muscle weakness, loss of movement control, and muscle wasting. Some neuromuscular diseases cause weakness of respiratory muscles (diaphragm and accessory muscles of respiration). The decline of respiratory muscle function in these diseases affects activities of daily living and quality of life. Respiratory muscle training could potentially be considered as an extra therapy for people with suspected or confirmed respiratory muscle weakness. </p> <p><b>Study characteristics</b> </p> <p>This review included 11 studies with a total of 250 randomized participants with neuromuscular disease. Six studies included 112 young males (including children) with Duchenne muscular dystrophy, which is an inherited muscle disease. One trial involved 23 adults with other muscle diseases (Becker muscular dystrophy and limb‐girdle muscular dystrophy). Three trials involved 88 people with amyotrophic lateral sclerosis, a progressive condition that affects the nerves controlling movement. One trial involved 27 people with myasthenia gravis, a condition that affects the signals between nerves and muscles. </p> <p><b>Key results</b> </p> <p>The studies showed that respiratory muscle training may result in some improvements in lung function for people with amyotrophic lateral sclerosis and Duchenne muscular dystrophy. However, this finding was not consistent between studies. Physical function and quality of life were only assessed in one amyotrophic lateral sclerosis trial, which indicated that RMT may have no clear effect. One trial reported on adverse events, but the certainty of evidence was too low for conclusions to be drawn. The studies did not report the number of unscheduled hospitalisations for sudden infection or worsening of chronic respiratory failure. </p> <p><b>Certainty of the evidence</b> </p> <p>The certainty of the evidence examined as part of this review was low or very low. Low‐certainty evidence means that our confidence in the effect of respiratory muscle training is limited, and the true effect may be substantially different. When the evidence is of very low‐certainty, the true effect is likely to be substantially different. Given the low or very low‐certainty of the evidence presented in the studies, we believe that there is a need for more well‐conducted studies in order to assess the efficacy of respiratory muscle training in people with NMD. </p> <p>The evidence is current to November 2018.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011711-sec-0150" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011711-sec-0150">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011711-sec-0215">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011711-sec-0150"></div> <h3 class="title" id="CD011711-sec-0151">Implications for practice</h3> <section id="CD011711-sec-0151"> <p>We found low‐certainty evidence that respiratory muscle training (RMT) may improve lung capacity and respiratory muscle strength in some neuromuscular diseases (NMDs). Moreover there may be no meaningful difference in physical functioning or in quality of life in people with amyotrophic lateral sclerosis (ALS). It is uncertain whether RMT causes adverse effects, as the quality of evidence is very low. Thus, there is no definitive evidence in this review about the effect of RMT for NMDs. </p> <p>Due to clinical heterogeneity between the trials and small number of participants included in the analysis, together with a high risk of bias, the results must be interpreted very cautiously. In the future, the inclusion of more randomized controlled trials (RCTs) with a low risk of bias would be likely to have an important impact on our confidence in the estimate of effect for the outcomes investigated. Thus, the assessment of the effects of RMT in people with NMDs could change. </p> </section> <h3 class="title" id="CD011711-sec-0152">Implications for research</h3> <section id="CD011711-sec-0152"> <p>The quality of current evidence on this topic is low, thus we need well‐conducted RCTs to evaluate the clinical benefit of RMT in the management of people with NMDs. More attention needs to be paid to high‐quality study design and reporting, including items such as determination of the trial sample size before the beginning of the study, adequate random sequence generation and allocation concealment, blinding of the outcome assessor and, when possible, of participants. If there is attrition of participants, an intention‐to‐treat analysis must be performed. Moreover, results should be reported following CONSORT guidelines (<a href="./references#CD011711-bbs2-0040" title="MoherD , HopewellS , SchulzKF , MontoriV , GøtzschePC , DevereauxPJ , et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology2010;63(8):834‐40. ">CONSORT 2010</a>). Studies that assess more than one type of NMD should present results for each condition separately, because the effects of RMT may be different for each type of disease. </p> <p>In order to draw firm conclusions, future trials should enrol people with NMDs that cause impairment of respiratory muscles, since we identified only seven eligible studies, with small sample size for this review. NMDs that cause impairment of respiratory muscles include muscular dystrophies such as Becker muscular dystrophy (BMD), Duchenne muscular dystrophy (DMD), limb‐girdle, Emery‐Dreifuss, and facioscapulohumeral muscular dystrophy, myotonic dystrophy, metabolic and congenital myopathies, inflammatory myopathies, myasthenia gravis, neuropathies (hereditary and acquired), ALS, poliomyelitis, and spinal muscular atrophy. The diagnostic criteria, disease stage, sex, and age of participants, respiratory muscle weakness (inspiratory, expiratory or both) and inclusion and exclusion criteria must also be specified. </p> <p>Few trials have performed expiratory muscle training (EMT) or inspiratory muscle training (IMT) plus EMT, and the main comparisons of interest in this review were sham training and no training. More adequate RCTs comparing RMT with sham training and no training are necessary, because there was not sufficient evidence about efficacy of the intervention. Particular attention should be given to FITT components (<b>F</b> requency, <b>I</b> ntensity, <b>T</b> ime and <b>T</b>ype of exercise). </p> <p>The trials should investigate important outcomes, including physical functioning in activities of daily living, quality of life, and the number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure. Furthermore, attention must be paid to adverse effects that could arise during training, i.e. dyspnoea, tachypnoea, desaturation, haemodynamic instability, and respiratory fatigue. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011711-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011711-sec-0036"></div> <div class="table" id="CD011711-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Respiratory muscle training versus sham training in ALS</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Respiratory muscle training compared to sham training in ALS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with ALS<br/> <b>Intervention:</b> respiratory muscle training<br/> <b>Comparison:</b> sham training </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with sham training</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with respiratory muscle training</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> <p>(change from baseline in % predicted FVC)<br/> Follow‐up: 8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in % predicted FVC in the control group was ‐8.3%</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in % predicted FVC in the training group was 0.70% less of a decline than in the sham training group (8.48 more of a decline to 9.88 less of a decline) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> (change from baseline in % predicted FVC)<br/> Follow‐up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in % predicted FVC in the control group was ‐5.20%<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in % predicted FVC in the training group was 10.86% less of a decline than in the sham training group<br/> (4.25 more of a decline to 25.97 less of a decline) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RMT may improve lung capacity in comparison to sham training in the medium term</p> <p>The MCID for FVC, based on estimations in idiopathic pulmonary fibrosis is 2% to 6% (<a href="./references#CD011711-bbs2-0046" title="du BoisRM , WeyckerD , AlberaC , BradfordWZ , CostabelU , KartashovA , et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. American Journal of Respiratory Critical Care Medicine2011;184(12):1382‐9. ">du Bois 2011</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function in carrying out activities of daily living</b> over the medium term (3 to 12 months; change from baseline)<br/> Assessed with: ALSFRS (maximum possible total score 40)<br/> Follow‐up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The estimated mean change in the control group was ‐3.80<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in physical function assessed with ALSFRS was</p> <p>0.85 points less of a decline than in the sham training group (2.16 more of a decline to 3.85 less of a decline) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There may be no clinically meaningful difference in ALSFRS score between training and sham training groups in the medium term. </p> <p>Higher scores on the ALSFRS indicate better physical functioning.</p> <p>There is no established MCID for ALSFRS, but as the scale ranges from 0 to 40, we judged less than 1 point to be too small to make a difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> (change from baseline) in the medium term<br/> Assessed with: EuroQol‐5D, a 0 to 100 point visual analogue scale. The bottom rate (0) corresponds to " the worst health you can imagine", and the highest rate (100) corresponds to "the best health you can imagine"<br/> Follow‐up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the control group was not available</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in quality of life score in the training group was MD 0.77 less of a decline<br/> (17.09 more of a decline to 18.62 less of a decline) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There may be no clinically important difference in EuroQol score between the training and sham training groups in the medium term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>One 4‐month trial of IMT in 24 people with ALS reported that no adverse event occurred.</p> <p>A second ALS trial, in 14 participants with ALS, did not provide information on adverse events. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The certainty of the available evidence on RMT in ALS was too low for conclusions to be drawn about adverse events. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>ALS:</b> amyotrophic lateral sclerosis; <b>ALSFRS:</b> Amyotrophic Lateral Sclerosis Functional Rating Scale; <b>CI:</b> confidence interval; <b>FEV₁:</b> forced expiratory volume in one second; <b>FVC:</b> forced vital capacity; <b>IMT:</b> inspiratory muscle training; <b>MCID:</b> minimum clinically important difference; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial; <b>RMT</b>: respiratory muscle training </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The control group data were obtained from graphical representation of some outcomes, which included all participants who completed the study period (N = 9). Another study (N = 14) measured FVC and FEV₁ in the short term but was only published as an abstract and provided no data.<br/> <sup>b</sup>We downgraded the evidence twice for serious imprecision due to small sample size and because the CIs included both an important effect and no effect.<br/> <sup>c</sup>We downgraded the evidence three times: once because this outcome was at high risk of bias due to reporting bias, and twice for serious imprecision due to small sample and low event rate (no events). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011711-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Respiratory muscle training versus sham training in DMD</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Respiratory muscle training compared to sham training in DMD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children and young males with DMD<br/> <b>Intervention:</b> respiratory muscle training<br/> <b>Comparison:</b> sham training </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with sham training<sup>a</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with respiratory muscle training</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> <p>Measured by: post‐intervention TLC<br/> Follow‐up: 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention TLC in the sham training group was 2.79 L</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention TLC was 0.45 L higher than in the sham training group<br/> (0.24 lower to 1.14 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RMT may slightly increase TLC in comparison to sham training. For this study, a difference of 0.45 L represents approximately a 16% difference from the control group. </p> <p>A second trial did not report TLC but found no clear difference in FVC between RMT and sham training groups after 18 days (MD 0.16 L, 95% CI ‐0.31 to 0.63; N = 20). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function in carrying out activities of daily living</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of unscheduled hospitalizations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two trials with 16 and 20 participants with DMD did not provide information on adverse events </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DMD:</b> Duchenne muscular dystrophy; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial; <b>TLC:</b> total lung capacity </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The control group data were obtained from graphical representation of some outcomes, which included all participants who completed the study period (N = 9).<br/> <sup>b</sup>We downgraded the evidence twice for serious imprecision due to a small sample size and because CIs included both an important effect and no effect. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011711-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Respiratory muscle training versus no training in DMD</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Respiratory muscle training compared to no training in DMD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children and young males with DMD<br/> <b>Intervention:</b> respiratory muscle training<br/> <b>Comparison:</b> no training </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with no training</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with respiratory muscle training</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Three cross‐over trials measured short‐term outcomes but did not provide data for each study period. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> </p> <p>Measured by: post‐intervention % predicted VC<br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention % predicted VC was 44.4%</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention % predicted VC was 3.50% higher than in the no training group<br/> (14.35% lower to 21.35% higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There may be no clear difference in % predicted VC with RMT in comparison to no training.</p> <p>For more lung capacity outcomes, see text.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function in carrying out activities of daily living</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of unscheduled hospitalizations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>DMD:</b> Duchenne muscular dystrophy; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial; <b>VC:</b> vital capacity </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the evidence twice for serious imprecision due to small sample size and the CIs included both an important effect and no effect. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011711-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in limb‐girdle muscular dystrophy or Becker muscular dystrophy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with limb‐girdle muscular dystrophy or Becker muscular dystrophy </p> <p><b>Intervention:</b> respiratory muscle training </p> <p><b>Comparison:</b> breathing exercises </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with breathing exercises</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RMT</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> <p>Measured as change from baseline in FVC (L)</p> <p>follow‐up: 12 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in FVC in the breathing exercises group was 0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>FVC decreased on average 0.01 L more (0.11 less to 0.13 more) in the RMT group than the breathing exercises group. (The mean change in FVC in the RMT group was a decrease of 0.01 L) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The effect of RMT on FVC, when compared to breathing exercises, is uncertain</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Physical function in carrying out activities of daily living</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>All adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>FVC</b> : forced vital capacity; <b>RCT</b> : randomized controlled trial; <b>RMT</b>: respiratory muscle training </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the certainty of evidence for this outcome to very low, downgrading two levels for very serious imprecision as the sample size was very small and because the CI included both an important effect and no effect, and once for study limitations as the trial was quasi‐randomized (alternate allocation). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011711-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in myasthenia gravis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Respiratory muscle training compared to breathing exercises in myasthenia gravis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with myasthenia gravis<br/> <b>Intervention:</b> respiratory muscle training<br/> <b>Comparison:</b> breathing exercises </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with breathing exercises</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with respiratory muscle training</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> <p>Measured by: post‐intervention TLC<br/> Follow‐up: 8 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention TLC was 4.7 L</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention TLC was 0.20 lower than in the breathing exercises group<br/> (‐1.07 lower to 0.67 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RMT, compared to breathing exercises, may have no clear effect on lung capacity.</p> <p>For other lung capacity outcomes, see text.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function in carrying out activities of daily living</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The trial authors reported narratively that a change in one of the nine SF‐36 domains (physical role functioning) showed a improvement in the training group compared to the breathing exercises group </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether RMT has an effect on quality of life in comparison to breathing exercises </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of unscheduled hospitalizations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomized controlled trial; <b>RMT</b> : respiratory muscle training; <b>SF‐36:</b> 36‐Item Short Form Health Survey; <b>TLC:</b> total lung capacity </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the evidence three times: once because the trials providing data for this outcome were at high risk of bias, and twice for serious imprecision due to small sample size and the CIs included both an important effect and no effect.<br/> <sup>b</sup>We downgraded the evidence three times: twice because this outcome was at high risk of bias due to reporting bias, and once for serious imprecision due to the small sample. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011711-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011711-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011711-sec-0171">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011711-sec-0037"></div> <section id="CD011711-sec-0038"> <h3 class="title" id="CD011711-sec-0038">Description of the condition</h3> <p>Neuromuscular diseases (NMDs) are a heterogeneous group of conditions that impair muscle function through pathologies of the anterior horn cell of spinal cord, neuromuscular junction, peripheral nerves and muscles (<a href="./references#CD011711-bbs2-0034" title="AnziskaY , SternbergA . Exercise in neuromuscular disease. Muscle &amp; Nerve2013;48(1):3‐20. ">Anziska 2013</a>). The clinical characteristics of NMDs are based on where the lesion occurs and these lesions can be found anywhere between the anterior horn cells of the spinal cord and the skeletal muscle (<a href="./references#CD011711-bbs2-0099" title="RezaniaK , GoldenbergFD , WhiteS . Neuromuscular disorders and acute respiratory failure: diagnosis and management. Neurologic Clinics2012;30(1):161–85. ">Rezania 2012</a>). People with NMDs may present with muscle weakness, loss of spontaneous movement, involuntary muscle activity, and muscle atrophy (<a href="./references#CD011711-bbs2-0114" title="WijdicksEF . Generalized weakness in the intensive care unit. Neurological Complications of Critical Illness. Oxford: Oxford University Press, 2009:59‐74. ">Wijdicks 2009</a>). </p> <p>Generally, children are affected by hereditary NMDs (<a href="./references#CD011711-bbs2-0053" title="Estournet‐MathiaudB . Respiratory complications of neuromuscular diseases [Complications respiratoires des maladies neuromusculaires]. In: DutauG , LabbéA editor(s). Pneumologie de l'Enfant. 2nd Edition. Paris: Arnette, Blackwell, 2003:273‐83. ">Estournet‐Mathiaud 2003</a>; <a href="./references#CD011711-bbs2-0075" title="MacDonaldCM . Physical activity, health impairments, and disability in neuromuscular disease. Journal of American Journal of Physical Medicine and Rehabilitation2002;81(11 Suppl):S108‐20. ">MacDonald 2002</a>; <a href="./references#CD011711-bbs2-0096" title="ReedUC . Neuromuscular diseases [Doenças neuromusculares]. Jornal de Pediatria2002;78(Suppl 1):S89‐103. ">Reed 2002</a>), while acquired NMDs are more common in adults (<a href="./references#CD011711-bbs2-0096" title="ReedUC . Neuromuscular diseases [Doenças neuromusculares]. Jornal de Pediatria2002;78(Suppl 1):S89‐103. ">Reed 2002</a>). A conservative estimate of overall prevalence among both sexes for the most common forms of muscular dystrophy, myotonic dystrophy and congenital myotonias, proximal spinal muscular atrophies, and hereditary motor and sensory neuropathies is 1 in 3500 of the general population (<a href="./references#CD011711-bbs2-0049" title="EmeryAE . Population frequencies of inherited neuromuscular diseases ‐ a world survey. Neuromuscular Disorders1991;1(1):19‐29. ">Emery 1991</a>). If numbers include severe disorders that manifest only in infancy and early childhood, and the rare forms of dystrophy and myopathy, the overall prevalence could well exceed 1 in 3000 (<a href="./references#CD011711-bbs2-0049" title="EmeryAE . Population frequencies of inherited neuromuscular diseases ‐ a world survey. Neuromuscular Disorders1991;1(1):19‐29. ">Emery 1991</a>). </p> <p>NMDs cause physical disability, usually through progressive skeletal muscle weakness, and in some conditions this includes respiratory muscle (diaphragm and accessory muscles of respiration) weakness (<a href="./references#CD011711-bbs2-0056" title="FinderJD , BirnkrantD , CarlJ , FarberHJ , GozalD , IannacconeST , et al. American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: ATS Consensus Statement. American Journal of Respiratory and Critical Care Medicine2004; Vol. 170, issue 4:456‐65. ">Finder 2004</a>; <a href="./references#CD011711-bbs2-0078" title="McDonaldCM . Clinical approach to the diagnostic evaluation of hereditary and acquired neuromuscular diseases. Physical Medicine &amp; Rehabilitation Clinics of North America2012;23(3):495‐563. ">McDonald 2012</a>; <a href="./references#CD011711-bbs2-0092" title="PustavoitauA , StevensRD . Mechanisms of neurologic failure in critical illness. Critical Care Clinics2008;24(1):1‐24. ">Pustavoitau 2008</a>). Dysfunction at any level of the respiratory pathway, from the central nervous system, peripheral nerves, or neuromuscular junction, to the muscles themselves can cause respiratory failure, a condition in which the respiratory system fails in one or both of its gas exchange functions: oxygenation and carbon dioxide elimination (<a href="./references#CD011711-bbs2-0077" title="McCoolFD , TzelepisGE . Inspiratory muscle training in the patient with neuromuscular disease. Physical Therapy1995;75(11):1006‐14. ">McCool 1995</a>). NMDs that cause respiratory muscle weakness include muscular dystrophies, such as Becker muscular dystrophy (BMD), Duchenne muscular dystrophy (DMD), limb‐girdle, Emery‐Dreifuss and facioscapulohumeral muscular dystrophy, myotonic dystrophy, metabolic and congenital myopathies, inflammatory myopathies, myasthenia gravis, neuropathies (hereditary and acquired), amyotrophic lateral sclerosis (ALS), poliomyelitis, and spinal muscular atrophy (<a href="./references#CD011711-bbs2-0086" title="PaschoalIA , VillalbaWO , PereiraMC . Chronic respiratory failure in patients with neuromuscular diseases: diagnosis and treatment [Insuficiência respiratória crônica nas doenças neuromusculares: diagnóstico e tratamento]. Jornal Brasileiro de Pneumologia2007;33(1):81‐92. ">Paschoal 2007</a>). </p> <p>NMDs have variable effects on respiratory muscles with regard to the site of the pathology and the severity, yet the major complication is respiratory failure (<a href="./references#CD011711-bbs2-0116" title="WirthB , HerzM , WetterA , MoskauS , HahnenE , Rudnik‐SchönebornS , et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype‐phenotype correlation, and implications for genetic counseling. American Journal of Human Genetics1999;64(5):1340‐56. ">Wirth 1999</a>). Respiratory impairment includes ventilatory difficulty, decreased vital capacity and reduced chest wall expansion due to inspiratory muscle weakness. Signs of respiratory failure may include dyspnoea (shortness of breath) from slight effort, dyspnoea and tachypnoea (abnormally fast breathing) at rest, use of respiratory accessory muscles (indicating effortful breathing), paradoxical respiration (abnormal movement of the diaphragm), orthopnoea (shortness of breath lying down), poor sleep, morning headache, daytime fatigue or daytime sleepiness, and an ineffective cough (<a href="./references#CD011711-bbs2-0089" title="PintoS , deCarvalhoM . Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients. Neurodegenerative Disease Management2014;4(1):83‐102. ">Pinto 2014</a>). </p> <p>Difficulty coughing due to weakness of expiratory, inspiratory and upper airway muscles can cause atelectasis (closure or collapse of lung tissue) and infections. Upper airway weakness can raise the risk of fluid aspiration (<a href="./references#CD011711-bbs2-0035" title="BendittJO . The neuromuscular respiratory system: physiology, pathophysiology, and a respiratory care approach to patients. Respiratory Care2006;51(8):829‐39. ">Benditt 2006</a>; <a href="./references#CD011711-bbs2-0077" title="McCoolFD , TzelepisGE . Inspiratory muscle training in the patient with neuromuscular disease. Physical Therapy1995;75(11):1006‐14. ">McCool 1995</a>). Both inspiratory and expiratory muscles are needed to produce a cough strong enough to maintain upper airway patency (<a href="./references#CD011711-bbs2-0085" title="ParkJH , KangSW , LeeSC , ChoiWA , KimDH . How respiratory muscle strength correlates with cough capacity in patients with respiratory muscle weakness. Yonsei Medical Journal2010;51(3):392‐7. ">Park 2010</a>). In people with NMD, inspiratory and expiratory muscle weakness is thus related to inadequate alveolar ventilation and poor airway clearance, which increase the risk of atelectasis, pneumonia, and chronic respiratory insufficiency (<a href="./references#CD011711-bbs2-0033" title="AmbrosinoN , CarpeneN , GherardiM . Chronic respiratory care for neuromuscular diseases in adults. European Respiratory Journal2009;34(2):444‐51. ">Ambrosino 2009</a>; <a href="./references#CD011711-bbs2-0042" title="D'AngeloMG , RomeiM , Lo MauroA , MarchiE , GandossiniS , BonatoS . Respiratory pattern in an adult population of dystrophic patients. Journal of the Neurological Sciences2011;306(1‐2):54‐61. ">D'Angelo 2011</a>; <a href="./references#CD011711-bbs2-0079" title="MisuriG , LaniniB , GigliottiF , IandelliI , PizziA , BertoliniMG . Mechanism of CO2 retention in patients with neuromuscular disease. Chest2000;117(2):447‐53. ">Misuri 2000</a>). </p> <p>The deterioration of respiratory muscle function in these diseases, in addition to effects on lung function, reduces functional capacity, limits activities of daily living, and limits quality of life (<a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). Furthermore, it precipitates the onset of respiratory failure (<a href="./references#CD011711-bbs2-0057" title="FittingFW . Sniff nasal inspiratory pressure: simple or too simple?. European Respiratory Journal2006;27(5):881‐3. ">Fitting 2006</a>; <a href="./references#CD011711-bbs2-0095" title="Ramirez‐SarmientoA , Orozco‐LeviM . Pulmonary rehabilitation should be prescribed in the same way medications are prescribed. Archivos de Bronconeumología2008;44(3):119‐21. ">Ramirez‐Sarmiento 2008</a>), and contributes significantly to morbidity and mortality (<a href="./references#CD011711-bbs2-0041" title="CupEH , PieterseAJ , TenBroek‐PastoorJM , MunnekeM , vanEngelenBG , HendricksHT , et al. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Archives of Physical Medicine and Rehabilitation2007;88(11):1452‐64. ">Cup 2007</a>; <a href="./references#CD011711-bbs2-0061" title="HapkeEJ , MeekJC , JacobsJ . Pulmonary function in progressive muscular dystrophy. Chest1972;61(1):41‐7. ">Hapke 1972</a>; <a href="./references#CD011711-bbs2-0091" title="PontesJF , FerreiraGM , FregoneziGA , Sena‐EvangelistaKC , DouradoMEJr . Respiratory muscle strength, nutritional and postural profile in children with neuromuscular diseases [Força muscular respiratória e perfil postural e nutricional em crianças com doenças neuromusculares]. Fisioterapia em Movimento2012;25(2):253‐61. ">Pontes 2012</a>). </p> <p>Respiratory muscle training (RMT) could be considered a possible adjunctive therapy for people with suspected or confirmed respiratory muscle weakness (<a href="./references#CD011711-bbs2-0082" title="NiciL , DonnerC , WoutersE , ZuwallackR , AmbrosinoN , BourbeauJ , et al. ATS/ERS Pulmonary Rehabilitation Writing Committee. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine2006;173(12):1390‐413. ">Nici 2006</a>). </p> </section> <section id="CD011711-sec-0039"> <h3 class="title" id="CD011711-sec-0039">Description of the intervention</h3> <p>RMT is a technique that aims to increase the strength or endurance of respiratory muscles (<a href="./references#CD011711-bbs2-0051" title="EnrightSJ , UnnithanVB . Effect of inspiratory muscle training intensities on pulmonary function and work capacity in people who are healthy: a randomized controlled trial. Physical Therapy2011;91(6):894‐905. ">Enright 2011;</a><a href="./references#CD011711-bbs2-0081" title="MoodieLH , ReeveJC , VermeulenN , ElkinsMR . Inspiratory muscle training to facilitate weaning from mechanical ventilation: protocol for a systematic review. BMC Research Notes2011;4:283. ">Moodie 2011</a>). RMT can be classified into inspiratory muscle training (IMT) and expiratory muscle training (EMT). </p> <p>Two different forms of RMT have predominantly been employed: respiratory muscle endurance training (RMET) and respiratory muscle strength training (RMST). RMET involves low pressure and high flow loads of both inspiratory and expiratory muscles (<a href="./references#CD011711-bbs2-0063" title="HillK , JenkinsSC , HillmanDR , EastwoodPR . Dyspnoea in COPD: can inspiratory muscle training help?. Australian Journal of Physiotherapy2004;50(3):169‐80. ">Hill 2004</a>). This training is undertaken by means of normocapnic hyperpnoea, which requires maintenance of high levels of ventilation for an extended period of time (<a href="./references#CD011711-bbs2-0088" title="PineM , WatsfordM . Specific respiratory muscle training for athletic performance. Sports Coach2005;27(4):1‐4. ">Pine 2005</a>). In contrast, RMST involves high pressure and low flow loading of specific inspiratory or expiratory muscles (<a href="./references#CD011711-bbs2-0063" title="HillK , JenkinsSC , HillmanDR , EastwoodPR . Dyspnoea in COPD: can inspiratory muscle training help?. Australian Journal of Physiotherapy2004;50(3):169‐80. ">Hill 2004</a>). According to <a href="./references#CD011711-bbs2-0067" title="IlliSK , HeldU , FrankI , SpenglerCM . Effect of respiratory muscle training on exercise performance in healthy individuals: a systematic review and meta‐analysis. Sports Medicine2012;42(8):707‐24. ">Illi 2012</a>, "RMST is performed by breathing against an external inspiratory or expiratory load. This load consists either of a flow‐dependent resistance or a pressure threshold that needs to be overcome and sustained to generate flow". </p> <p>The type of RMT used has been targeted to the type of muscle weakness present, thus, IMT is used for inspiratory muscle weakness and EMT for expiratory weakness (<a href="./references#CD011711-bbs2-0013" title="AslanGK , GursesHN , IsseverH , KiyanE . Effects of respiratory muscle training on pulmonary functions in patients with slowly progressive neuromuscular disease: a randomized controlled trial. Clinical Rehabilitation2014;28(6):573‐81. ">Aslan 2014</a>). RMT can be performed from the early stages of the disease (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>), and can be undertaken with children (<a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>). Training sessions can be held in rehabilitation centers or at home (<a href="./references#CD011711-bbs2-0013" title="AslanGK , GursesHN , IsseverH , KiyanE . Effects of respiratory muscle training on pulmonary functions in patients with slowly progressive neuromuscular disease: a randomized controlled trial. Clinical Rehabilitation2014;28(6):573‐81. ">Aslan 2014</a>; <a href="./references#CD011711-bbs2-0014" title='CheahB , BolandR , BrodatyN , ZoingM , JefferyS , McKenzieD , et al. "Inspirational" ‐ Inspiratory muscle training in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 20th International Symposium on ALS/MND; 2009 Dec 8‐10; Berlin, Germany. 2009. CheahBC , BolandRA , BrodatyNE , ZoingMC , JefferySE , McKenzieDK , et al. INSPIRATIonAL ‐ INSPIRAtory muscle training in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2009;10(5‐6):384‐92. '>Cheah 2009</a>; <a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>; <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>). </p> <p>The results of RMT have been mixed, with some studies showing improvement in respiratory muscle performance, while others report minimal or insignificant changes (<a href="./references#CD011711-bbs2-0030" title="AboussouanLS . Mechanisms of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease. Chronic Respiratory Disease2009;6(4):231‐49. ">Aboussouan 2009</a>; <a href="./references#CD011711-bbs2-0056" title="FinderJD , BirnkrantD , CarlJ , FarberHJ , GozalD , IannacconeST , et al. American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: ATS Consensus Statement. American Journal of Respiratory and Critical Care Medicine2004; Vol. 170, issue 4:456‐65. ">Finder 2004</a>; <a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>). In children with DMD, the protective mechanism of nitric oxide during exercise is defective. The data indicate that sympathetic vasoconstriction and defective modulation in the exercising muscle can produce functional muscle ischemia (<a href="./references#CD011711-bbs2-0103" title="SanderM , ChavoshanB , HarrisSA , IannacconeST , StullJT , ThomasGD , et al. Functional muscle ischemia in neuronal nitric oxide synthase‐deficient skeletal muscle of children with Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the Unites States of America2000;97(25):13818‐23. ">Sander 2000</a>). Thus, for children with DMD, the implementation of respiratory training protocols could possibly result in an increase in muscle damage (<a href="./references#CD011711-bbs2-0056" title="FinderJD , BirnkrantD , CarlJ , FarberHJ , GozalD , IannacconeST , et al. American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: ATS Consensus Statement. American Journal of Respiratory and Critical Care Medicine2004; Vol. 170, issue 4:456‐65. ">Finder 2004</a>), because progressive muscle fibrosis may be accelerated when muscles deficient in dystrophin and neuronal nitric oxide synthase undergo repeated bouts of ischemic exercise (<a href="./references#CD011711-bbs2-0103" title="SanderM , ChavoshanB , HarrisSA , IannacconeST , StullJT , ThomasGD , et al. Functional muscle ischemia in neuronal nitric oxide synthase‐deficient skeletal muscle of children with Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the Unites States of America2000;97(25):13818‐23. ">Sander 2000</a>). </p> </section> <section id="CD011711-sec-0040"> <h3 class="title" id="CD011711-sec-0040">How the intervention might work</h3> <p>The respiratory muscles are morphologically and functionally skeletal muscles, and respond to training in the same way as any muscle of the locomotor system (<a href="./references#CD011711-bbs2-0102" title="RomerLM , McConnellAK . Specificity and reversibility of inspiratory muscle training. Medicine and Science in Sports Exercise2003;35(2):237‐44. ">Romer 2003</a>). Thus, RMT follows the same principles as those employed in training skeletal muscles: specificity, intensity, frequency, duration, and reversibility (<a href="./references#CD011711-bbs2-0074" title="LeithDE , BradleyM . Ventilatory muscle strength and endurance training. Journal of Applied Physiology1976;41(4):508‐16. ">Leith 1976</a>). Specificity refers to adapting the training to be specific to the system or to the muscles being trained (<a href="./references#CD011711-bbs2-0064" title="HoffmanJ . Physiological Aspects of Sport Training and Performance. Champaign, IL: Human Kinetics, 2002. ">Hoffman 2002</a>). Training conducted at high load and with a low speed of muscle contraction promotes an increase in inspiratory muscle strength, while training employing high speed and low load has been shown to increase endurance (<a href="./references#CD011711-bbs2-0102" title="RomerLM , McConnellAK . Specificity and reversibility of inspiratory muscle training. Medicine and Science in Sports Exercise2003;35(2):237‐44. ">Romer 2003</a>; <a href="./references#CD011711-bbs2-0109" title="TzelepisGE , VegaDL , CohenME , FulambarkerAM , PatelKK , McCoolFD . Pressure‐flow specificity of inspiratory muscle training. Journal of Applied Physiology1994;77(2):795‐801. ">Tzelepis 1994</a>; <a href="./references#CD011711-bbs2-0110" title="TzelepisGE , KasasV , McCoolFD . Inspiratory muscle adaptations following pressure or flow training in humans. European Journal of Applied Physiology1999;79(6):467‐71. ">Tzelepis 1999</a>). The principle of intensity indicates that the exercise load must be greater than the muscular capacity to overcome it and it therefore must be adjusted during the training protocol (<a href="./references#CD011711-bbs2-0089" title="PintoS , deCarvalhoM . Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients. Neurodegenerative Disease Management2014;4(1):83‐102. ">Pinto 2014</a>). Training loads above 22% of maximal inspiratory pressure (MIP) are able to improve the endurance of inspiratory muscles, while loads of at least 30% of MIP are necessary to increase the strength of these muscles (<a href="./references#CD011711-bbs2-0063" title="HillK , JenkinsSC , HillmanDR , EastwoodPR . Dyspnoea in COPD: can inspiratory muscle training help?. Australian Journal of Physiotherapy2004;50(3):169‐80. ">Hill 2004</a>). The duration and frequency of training sessions determines the magnitude of muscle response and the time needed for benefits to accrue (<a href="./references#CD011711-bbs2-0089" title="PintoS , deCarvalhoM . Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients. Neurodegenerative Disease Management2014;4(1):83‐102. ">Pinto 2014</a>). Reversibility means that fitness levels will eventually return to baseline when a training stimulus is removed (<a href="./references#CD011711-bbs2-0064" title="HoffmanJ . Physiological Aspects of Sport Training and Performance. Champaign, IL: Human Kinetics, 2002. ">Hoffman 2002</a>). </p> <p>The strength that skeletal muscle can generate depends on the effective cross‐sectional area and the geometry of the way in which the tension force is applied (<a href="./references#CD011711-bbs2-0104" title="SartoriR , BarbiE , PoliF , RonfaniL , MarchettiF , AmaddeoA , et al. Respiratory training with a specific device in cystic fibrosis: a prospective study. Journal of Cystic Fibrosis2008;7(4):313‐9. ">Sartori 2008</a>). The imposition of loads by RMT promotes greater muscle strength through neural adaptations (recruitment of additional motor units and an increase in frequency of muscle fibre contraction), adaptations of the muscle itself (hypertrophy), or both (<a href="./references#CD011711-bbs2-0052" title="EpsteinSK . An overview of respiratory muscle function. Clinics in Chest Medicine1994;15(4):619‐39. ">Epstein 1994</a>; <a href="./references#CD011711-bbs2-0065" title="HuangCH , YangGG , WuYT , LeeCW . Comparison of inspiratory muscle strength training effects between older subjects with and without chronic obstructive pulmonary disease. Journal of the Formosan Medical Association2011;110(8):518‐26. ">Huang 2011</a>). The response of muscle to training is specific: strength training will enhance the number and volume of muscle fibres (hypertrophy), while endurance training will increase the number of oxidative fibres and capillary density (<a href="./references#CD011711-bbs2-0089" title="PintoS , deCarvalhoM . Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients. Neurodegenerative Disease Management2014;4(1):83‐102. ">Pinto 2014</a>). </p> <p>In people with neurological and neurodegenerative diseases (e.g. multiple sclerosis, Parkinson's disease, spinal cord injury, and stroke), meta‐analysis shows that RMT increases inspiratory and expiratory muscle strength (<a href="./references#CD011711-bbs2-0036" title="BerlowitzDJ , TamplinJ . Respiratory muscle training for cervical spinal cord injury. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD008507.pub2] ">Berlowitz 2013</a>; <a href="./references#CD011711-bbs2-0090" title="PollockRD , RaffertyGF , MoxhamJ , KalraL . Respiratory muscle strength and training in stroke and neurology: a systematic review. International Journal of Stroke2013;8(2):124‐30. ">Pollock 2013</a>; <a href="./references#CD011711-bbs2-0098" title="ReyesA , ZimanM , NosakaK . Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review. Chest2013;143(5):1386‐94. ">Reyes 2013</a>; <a href="./references#CD011711-bbs2-0101" title="RietbergMB , VeerbeekJM , GosselinkR , KwakkelG , vanWegenEEH . Respiratory muscle training for multiple sclerosis. Cochrane Database of Systematic Reviews2017, Issue 12. [DOI: 10.1002/14651858.CD009424.pub2] ">Rietberg 2017</a>; <a href="./references#CD011711-bbs2-0111" title="VanHoutteS , VanlandewijckY , GosselinkR . Respiratory muscle training in persons with spinal cord injury: a systematic review. Respiratory Medicine2006;100(11):1886‐95. ">Van Houtte 2006</a>; <a href="./references#CD011711-bbs2-0117" title="XiaoY , LuoM , WangJ , LuoH . Inspiratory muscle training for the recovery of function after stroke. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD009360.pub2] ">Xiao 2012</a>), as well as improving vital capacity and residual volume (<a href="./references#CD011711-bbs2-0036" title="BerlowitzDJ , TamplinJ . Respiratory muscle training for cervical spinal cord injury. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD008507.pub2] ">Berlowitz 2013</a>; <a href="./references#CD011711-bbs2-0111" title="VanHoutteS , VanlandewijckY , GosselinkR . Respiratory muscle training in persons with spinal cord injury: a systematic review. Respiratory Medicine2006;100(11):1886‐95. ">Van Houtte 2006</a>). RMT has also been shown to promote greater exercise tolerance in healthy people and athletes (<a href="./references#CD011711-bbs2-0059" title="HajGhanbariB , YamabayashiC , BunaTR , CoelhoJD , FreedmanKD , MortonTA , et al. Effects of respiratory muscle training on performance in athletes: a systematic review with meta‐analysis. Journal of Strength and Conditioning Research2013;27(6):1643‐63. ">HajGhanbari 2013</a>; <a href="./references#CD011711-bbs2-0067" title="IlliSK , HeldU , FrankI , SpenglerCM . Effect of respiratory muscle training on exercise performance in healthy individuals: a systematic review and meta‐analysis. Sports Medicine2012;42(8):707‐24. ">Illi 2012</a>; <a href="./references#CD011711-bbs2-0076" title="McConnellAK . Respiratory muscle training as an ergogenic aid. Journal of Exercise Science &amp; Fitness2009;7(2):S18‐S27. ">McConnell 2009</a>). </p> </section> <section id="CD011711-sec-0041"> <h3 class="title" id="CD011711-sec-0041">Why it is important to do this review</h3> <p>The effects of RMT in people with NMD are uncertain. Some studies claim that after RMT, people with NMD have increased respiratory muscle strength, improved lung function, and reduced muscle fatigue (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>), and that RMT promotes a transient improvement in maximal voluntary ventilation, peak expiratory flow, and sniff inspiratory pressure (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>). Some have claimed that participation in RMT is a significant independent predictor of survival in people in the early stages of ALS (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>). Other studies, however, have discouraged the use of RMT because of the possibility of exceeding the force threshold and thereby damaging muscle fibres (<a href="./references#CD011711-bbs2-0030" title="AboussouanLS . Mechanisms of exercise limitation and pulmonary rehabilitation for patients with neuromuscular disease. Chronic Respiratory Disease2009;6(4):231‐49. ">Aboussouan 2009</a>; <a href="./references#CD011711-bbs2-0043" title="deGodoyVC , LanzillottaP . Respiratory muscle training in Becker's muscular dystrophy ‐ critical literature review [Treinamento muscular respiratório na distrofia muscular de Becker ‐ revisão crítica de literatura]. Revista Neurociências2012;20(1):138‐43. ">de Godoy 2012</a>; <a href="./references#CD011711-bbs2-0047" title="EagleM . Report on the Muscular Dystrophy Campaign workshop: exercise in neuromuscular diseases Newcastle, January 2002. Neuromuscular Disorders2002;12(10):975‐83. ">Eagle 2002</a>). </p> <p>To our knowledge, the published systematic reviews of RMT in NMDs included a mix of types of studies (i.e. randomized and non‐randomized studies; <a href="./references#CD011711-bbs2-0048" title="EidenbergerM , NowotnyS . Inspiratory muscle training in patients with amyotrophic lateral sclerosis: a systematic review. NeuroRehabilitation2014;35(3):349‐61. ">Eidenberger 2014</a>); a mix of neurodegenerative diseases (for example, multiple sclerosis and ALS; <a href="./references#CD011711-bbs2-0055" title="FerreiraGD , CostaAC , PlentzRD , CoronelCC , SbruzziG . Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta‐analysis. Physiotherapy2016;102(3):221‐8. ">Ferreira 2016</a>), or did not include adults with NMDs (<a href="./references#CD011711-bbs2-0066" title="HumanA , CortenL , JelsmaJ , MorrowB . Inspiratory muscle training for children and adolescents with neuromuscular diseases: A systematic review. Neuromuscular Disorders2017;27(6):503‐17. ">Human 2017</a>). Thus, a review is necessary to synthesize the best available evidence on the effectiveness and safety of RMT in people with NMD, to inform clinical practice. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011711-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011711-sec-0042">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011711-sec-0176">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011711-sec-0042"></div> <p>To assess the effects of respiratory muscle training (RMT) for neuromuscular disease (NMD) in adults and children, in comparison to sham training, no training, standard treatment, breathing exercises, or other intensities or types of RMT. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011711-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011711-sec-0043">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011711-sec-0177">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011711-sec-0043"></div> <section id="CD011711-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011711-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) and quasi‐RCTs (including cross‐over trials) and included studies reported as full text, those published as abstract only, and unpublished data. No restrictions were applied on language. Quasi‐RCTs are studies in which participants are allocated to groups by a method that is not completely random, for example, by odd or even medical record number, or by alternation. </p> </section> <section id="CD011711-sec-0046"> <h4 class="title">Types of participants</h4> <p>The participants in the studies included in this review were adults (age ≥18 years) and children (age &lt; 18 years) of both sexes with a diagnosis of neuromuscular disease (NMD) of any degree of severity, confirmed by an appropriate consensus definition or using diagnostic criteria defined by the trial authors. Participants were living in the community without the need for mechanical ventilation (invasive or non‐invasive), since positive pressure ventilation would be a confounding factor for some outcomes (i.e. lung capacity, physical functioning and quality of life) (<a href="./references#CD011711-bbs2-0060" title="HannanLM , DominelliGS , ChenYW , Darlene ReidW , RoadJ . Systematic review of non‐invasive positive pressure ventilation for chronic respiratory failure. Respiratory Medicine2014;108(2):229‐43. ">Hannan 2014</a>; <a href="./references#CD011711-bbs2-0094" title="RadunovicA , AnnaneD , RafiqMK , BrassingtonR , MustfaN . Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews2017, Issue 10. [DOI: 10.1002/14651858.CD004427.pub4] ">Radunovic 2017</a>). Trials including participants with and without ventilatory support were excluded if we were not able to obtain data separately. We considered for inclusion participants with myopathies, disorders of the neuromuscular junction and neuropathies and excluded people with acute respiratory failure and cognitive impairment. We also excluded studies that assessed more than one type of NMD (for example, myopathies and neuropathies) if we were not able to obtain results for each condition separately, because the effects of respiratory muscle training (RMT) could be different for each type of disease. </p> </section> <section id="CD011711-sec-0047"> <h4 class="title">Types of interventions</h4> <p>We considered trials for inclusion in which the intervention was RMT (inspiratory muscle training (IMT) or expiratory muscle training (EMT), or both) involving normocapnic hyperpnoea, resistive training, and pressure threshold loading, and where there was comparison with a control group using a sham, no training, standard treatment, different intensities of RMT (e.g. low versus high intensity), or different types of RMT (e.g. IMT versus IMT plus EMT), or breathing exercises (singing, deep breathing, diaphragmatic breathing, etc.). </p> <p>We considered all intervention protocols, regardless of the duration of training.</p> </section> <section id="CD011711-sec-0048"> <h4 class="title">Types of outcome measures</h4> <p>The outcomes listed below are not selection criteria for this review, but they are outcomes of interest within the included studies. </p> <section id="CD011711-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD011711-list-0001"> <li> <p><b>Measures of lung capacity</b> (e.g. total lung capacity (TLC), forced vital capacity (FVC)) over the short term (less than 3 months), medium term (greater than 3 months but less than 1 year), and long term (greater than 1 year). </p> </li> </ol> </p> </section> <section id="CD011711-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011711-list-0002"> <li> <p><b>Inspiratory muscle strength</b> over the short term (less than 3 months), medium term (greater than 3 months but less than 1 year), and long term (greater than 1 year), measured by maximal inspiratory pressure (MIP) and sniff nasal inspiratory pressure (SNIP). </p> </li> <li> <p><b>Expiratory muscle strength</b> over the short term (less than 3 months), medium term (greater than 3 months but less than 1 year), and long term (greater than 1 year), measured by maximal expiratory pressure (MEP). </p> </li> <li> <p><b>Physical function in carrying out activities of daily living</b> over the short term (less than 3 months), medium term (greater than 3 months but less than 1 year), and long term (greater than 1 year), measured by a validated instrument (e.g. Amyotrophic Lateral Sclerosis Functional Rating Scale‐Revised (ALSFRS‐R; <a href="./references#CD011711-bbs2-0039" title="CedarbaumJM , StamblerN , MaltaE , FullerC , ThurmondB , NakanishiA . The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences1999;169(1‐2):13‐21. ">Cedarbaum 1999</a>) and ACTIVLIM questionnaire; <a href="./references#CD011711-bbs2-0112" title="VanderveldeL , Van denBerghPY , GoemansN , ThonnardJL . Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire. Neuromuscular Disorders2009;19:99‐103. ">Vandervelde 2009</a>). </p> </li> <li> <p><b>Quality of life</b> over the short term (less than 3 months), medium term (greater than 3 months but less than 1 year), and long term (greater than 1 year), as measured by a validated questionnaire (e.g. 36‐Item Short Form Health Survey (SF‐36); <a href="./references#CD011711-bbs2-0113" title="WareJEJ , SherbourneCD . The MOS 36‐Item Short‐Form Health Survey (SF‐36). I. Conceptual framework and item selection. Medical Care1992;30(6):473‐83. ">Ware 1992</a>). </p> </li> <li> <p><b>Number of unscheduled hospitalisations for episodes of chest infections or acute exacerbation of chronic respiratory failure within the first year post‐randomization</b>. </p> </li> <li> <p><b>Adverse events</b>: including all adverse events (e.g. respiratory muscle fatigue during or after the training), measured by clinical criteria (e.g. increased respiratory rate, use of accessory respiratory muscles, and decrease in oxygen saturation); adverse events that require discontinuation of treatment; and serious adverse events, namely those that are life threatening, require or prolong a hospital stay, or are fatal. </p> </li> </ol> </p> <p>We specified that we would report the continuous outcomes as the change from baseline, and did so when these data were available. We otherwise reported final measurements. </p> </section> </section> </section> <section id="CD011711-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011711-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases on 19 November 2018.</p> <p> <ul id="CD011711-list-0003"> <li> <p>The Cochrane Neuromuscular Specialised Register via the Cochrane Register of Studies (CRS‐Web; <a href="./appendices#CD011711-sec-0156">Appendix 1</a>). </p> </li> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) via the Cochrane Register of Studies (CRS‐Web; <a href="./appendices#CD011711-sec-0157">Appendix 2</a>). </p> </li> <li> <p>MEDLINE (1946 to 18 November 2018; <a href="./appendices#CD011711-sec-0158">Appendix 3</a>). </p> </li> <li> <p>Embase (1974 to 18 November 2018; <a href="./appendices#CD011711-sec-0159">Appendix 4</a>). </p> </li> </ul> </p> <p>On 13 December 2018, we also searched the following clinical trials registries.</p> <p> <ul id="CD011711-list-0004"> <li> <p>US National Institutes for Health Clinical Trials Registry, ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>; <a href="./appendices#CD011711-sec-0160">Appendix 5</a>). </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>; <a href="./appendices#CD011711-sec-0160">Appendix 5</a>). </p> </li> </ul> </p> <p>We searched all databases from their inception to the present, and we imposed no restriction on language of publication or publication status. </p> </section> <section id="CD011711-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of all relevant studies and review articles for additional references. We searched relevant device manufacturers' websites for trial information. </p> </section> </section> <section id="CD011711-sec-0054"> <h3 class="title" id="CD011711-sec-0054">Data collection and analysis</h3> <section id="CD011711-sec-0055"> <h4 class="title">Selection of studies</h4> <p>Two review authors (RP, IGA) independently screened titles and abstracts of all the potential studies identified for inclusion in the review. We coded studies as 'retrieve' (eligible or potentially eligible/unclear) or 'do not retrieve'. We retrieved the full‐text reports and two review authors (RP, IGA) independently screened the full text and identified studies for inclusion, and identified and recorded reasons for exclusion of the ineligible studies. We resolved any disagreements through discussion or, if required, we consulted a third review author (GMHF). We identified and excluded duplicate papers. We also clustered multiple reports relating to the same study and considered them as only one included study. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and provide a 'Characteristics of excluded studies' table (<a href="./references#CD011711-bbs2-0080" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed1000097] ">Moher 2009</a>). </p> </section> <section id="CD011711-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>We used a data extraction form for study characteristics and outcome data that we piloted on at least one study in the review. Two review authors (ISS and IGA) extracted the following study characteristics from the included studies. </p> <p> <ol id="CD011711-list-0005"> <li> <p>Methods: study design, duration of study, details of any 'run‐in' period, number of study centers and locations, study settings, withdrawals, and date of study. </p> </li> <li> <p>Participants: number (total and in each intervention group), mean age, age range, gender, severity of condition, diagnostic criteria, baseline characteristics, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: intervention and comparison.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. When the change from baseline was not reported, we extracted the final values. </p> </li> <li> <p>Notes: funding for trial, and notable conflicts of interest of trial authors.</p> </li> </ol> </p> <p>Two review authors (ISS, IGA) independently extracted outcome data from the included studies. We noted if outcome data were not reported in a usable way in the 'Characteristics of included studies' table. We resolved disagreements by consensus or by involving a third review author (GMHF). One review author (ISS) transferred data into Review Manager 5 (<a href="./references#CD011711-bbs2-0097" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). A second review author checked the outcome data entries. Another review author (GMHF) spot‐checked study characteristics for accuracy against the trial report. </p> <p>We would have used scaling to combine results from studies using different periods. In the analysis, this would have required values from studies using periods not equal to one month to be divided by the period expressed in months. For example, for studies using a three‐week interval between measurement points, we would have divided the totals by 0.75; as no meta‐analysis was possible, this was not done. </p> <p>If reports had required translation, the translator would have extracted data directly using a data extraction form, or authors would have extracted data from the translation provided. When possible, a review author would have checked numerical data in the translation against the original study report. </p> </section> <section id="CD011711-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (ISS, RP) independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011711-bbs2-0062" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We resolved any disagreements by discussion or by involving a third review author (GMHF). We assessed and classified the risk of bias according to each of the following domains. </p> <p> <ol id="CD011711-list-0006"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Other bias.</p> </li> </ol> </p> <p>We graded each potential source of bias as high, low, or unclear and have provided a quote from the study report together with a justification for our judgement in the 'Risk of bias' table. We have summarized the 'Risk of bias' judgements across different studies for each of the domains listed. When information on risk of bias related to unpublished data or correspondence with a trialist, we also noted in the 'Risk of bias' table. 'Other bias' was a category of exclusion, for bias that did not fall into other domains. Where none was apparent we assessed the risk low unless information was very limited (e.g. an abstract), when we preferred unclear. </p> <p>When considering treatment effects, we took into account the risk of bias for the studies that contributed to that outcome. In addition, we planned to perform a sensitivity analysis in order to exclude studies at high risk of bias for allocation concealment. </p> <section id="CD011711-sec-0058"> <h5 class="title">Assessment of bias in conducting the systematic review</h5> <p>We conducted the review according to the published protocol (<a href="./references#CD011711-bbs2-0118" title="PedrosaR , SilvaIS , AzevedoIG , ForbesA‐M , FregoneziGA , Dourado JuniorME , et al. Respiratory muscle training in children and adults with neuromuscular disease. Cochrane Database of Systematic Reviews2015, Issue 5. [DOI: 10.1002/14651858.CD011711] ">Pedrosa 2015</a>), and reported any deviations from it in the <a href="#CD011711-sec-0166">Differences between protocol and review</a> section. </p> </section> </section> <section id="CD011711-sec-0059"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed continuous data as mean difference (MD), and would have reported a standardized mean difference (SMD) for results across studies with outcomes that were conceptually the same but measured in different ways, and dichotomous data as risk ratios (RRs). </p> <p>When means and SD for the analysis of changes from baseline were not available or calculable, we reported MDs between groups at the given time points. </p> <p>If the trials had not reported the mean and standard deviation (SD) for each group, we would have used generic inverse variance (GIV) to enter data in the analysis. We provided corresponding 95% confidence intervals (CIs) for measures of effect. We entered the data presented as a scale with a consistent direction of effect. </p> <p>We undertook a meta‐analysis only when this was meaningful (i.e. if the treatments, participants, and the underlying clinical questions were similar enough for pooling to be logical). </p> </section> <section id="CD011711-sec-0060"> <h4 class="title">Unit of analysis issues</h4> <p>We included cross‐over trials and reported data from the first treatment arm only. When the trials did not provide first period data, we contacted authors to request them. </p> <p>If a single trial had reported multiple trial arms, we planned to include only relevant arms, that is, those in which participants had received our prespecified interventions and comparators. If two comparisons (e.g. IMT versus placebo and EMT versus placebo) were combined in the same meta‐analysis, we would have halved the control group to avoid double‐counting. </p> </section> <section id="CD011711-sec-0061"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators or study sponsors in order to verify key study characteristics and obtain missing numerical outcome data (e.g. when a study was available as an abstract only). If we had assessed missing data as introducing serious bias, we would have explored the impact of including such studies in the overall assessment of results by employing a sensitivity analysis; however this would not have been possible as no more than two studies were included in any meta‐analysis. </p> </section> <section id="CD011711-sec-0062"> <h4 class="title">Assessment of heterogeneity</h4> <p>We would have used the I² statistic to measure heterogeneity among the trials. If we had identified substantial unexplained heterogeneity (I² &gt; 50%), we would have reported it and explored possible causes of clinical or methodological heterogeneity by undertaking prespecified subgroup analyses (<a href="./references#CD011711-bbs2-0045" title="DeeksJJ , HigginsJP , AltmanDG , editor(s) , on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> </section> <section id="CD011711-sec-0063"> <h4 class="title">Assessment of reporting biases</h4> <p>If we had been able to pool more than 10 trials, we would have created and examined a funnel plot in order to explore possible small‐study biases. </p> </section> <section id="CD011711-sec-0064"> <h4 class="title">Data synthesis</h4> <p>We would have used a fixed‐effect model to determine the effects of an intervention and performed a sensitivity analysis using a random‐effects model if there had been unexplained heterogeneity (<a href="./references#CD011711-bbs2-0062" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>As the review included more than one comparison that could not be considered in the same analysis, we reported the results for each comparison separately. Moreover, we decided against combining various types of NMDs. Thus, we entered data from studies with different types of NMDs into a forest plot for visual interpretation of the results but did not pool the data (i.e. the meta‐analysis diamond was turned off). </p> <p>Where meta‐analysis was not possible we reported results narratively.</p> <section id="CD011711-sec-0065"> <h5 class="title">'Summary of findings' table</h5> <p>We created a 'Summary of findings' table for each main comparison using the following outcomes. </p> <p> <ol id="CD011711-list-0007"> <li> <p><b>Measures of lung capacity</b> over the short term (less than 3 months), medium term (3 to 12 months), and long term (greater than 1 year). The order of choice for the presentation of the measures was as follows: total lung capacity (TLC), forced vital capacity (FVC), functional residual capacity (FRC), residual volume (RV), vital capacity (VC), and forced expiratory volume in one second (FEV₁). </p> </li> <li> <p><b>Physical function</b> in carrying out the activities of daily living in the medium term (3 to 12 months). </p> </li> <li> <p><b>Quality of life</b> in the medium term (3 to 12 months). </p> </li> <li> <p><b>Number of unscheduled hospitalisations</b> for episodes of chest infection or acute exacerbation of chronic respiratory failure within the first year post‐randomization. </p> </li> <li> <p><b>All adverse events</b>. </p> </li> </ol> </p> <p>We specified, when formulating outcomes, that we would report continuous outcomes as the change from baseline. When insufficient data were available to present the change from baseline, we reported the final values. </p> <p>We used five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence (studies that contribute data for prespecified outcomes). We employed methods and followed recommendations described in Chapter 11 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011711-bbs2-0062" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>), using GRADEpro software (<a href="./references#CD011711-bbs2-0058" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>). We justified all decisions to downgrade or upgrade the certainty of evidence using footnotes and we made comments to aid the reader's understanding of the review where necessary. </p> </section> </section> <section id="CD011711-sec-0066"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform the following subgroup analyses.</p> <p> <ol id="CD011711-list-0008"> <li> <p>Duration of intervention (less than 6 weeks and 6 weeks or more).</p> </li> <li> <p>Participant age (under 18 years of age and 18 years or above).</p> </li> </ol> </p> <p>We were intending to use the following outcomes in subgroup analyses.</p> <p> <ol id="CD011711-list-0009"> <li> <p>Frequency of unscheduled hospitalisation for episodes of acute exacerbation of chronic respiratory failure. </p> </li> <li> <p>Physical function in carrying out activities of daily living.</p> </li> </ol> </p> <p>We planned to use the formal test for subgroup interactions in Review Manager 5 (<a href="./references#CD011711-bbs2-0097" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <p>As the review included only one trial that assessed physical function, it was not possible to perform subgroup analyses. </p> </section> <section id="CD011711-sec-0067"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform the following sensitivity analyses.</p> <p> <ol id="CD011711-list-0010"> <li> <p>Repeat the analysis, excluding unpublished studies (if there were any).</p> </li> <li> <p>Repeat the analysis, excluding those studies at high risk of bias for allocation concealment.</p> </li> <li> <p>If there were one or more very large studies (100 or more participants per group), repeat the analysis, excluding these particular studies to determine their effect on the overall results. </p> </li> <li> <p>Repeat the analysis, excluding quasi‐RCTs.</p> </li> </ol> </p> <p>Most of the analyses were based on data from a single study, therefore we did not perform sensitivity analyses. </p> <section id="CD011711-sec-0068"> <h5 class="title">Reaching conclusions</h5> <p>We based our conclusions only on the findings from the synthesis of the quantitative and narrative data from the studies included in this review. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011711-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011711-sec-0069"></div> <section id="CD011711-sec-0070"> <h3 class="title">Description of studies</h3> <section id="CD011711-sec-0071"> <h4 class="title">Results of the search</h4> <p>We identified 504 references for possible inclusion in the review by the searches outlined in the appendices, of which 375 remained after deduplication. We identified 10 additional references by searching other resources (i.e. bibliographies of all relevant studies and international trials registers). After deduplication, there were 385 references. From these 385 references, two review authors selected 38 abstracts as potentially appropriate for inclusion in the review. After reading the full texts of these articles, we excluded 19 as not being relevant. Thus, 11 studies (reported in 19 references) fulfilled the inclusion criteria and are included in this review. </p> <p>One trial was ongoing (<a href="./references#CD011711-bbs2-0029" title="NCT02710110 . Respiratory strength training in persons with amyotrophic lateral sclerosis (ALS) [The impact of respiratory strength training in individuals with amyotrophic lateral sclerosis (ALS)]. clinicaltrials.gov/ct2/show/NCT02710110 (first posted 16 March 2016). [NCT02710110] ">NCT02710110</a>). </p> <p>We present a PRISMA diagram in <a href="#CD011711-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011711-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011711-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011711-sec-0072"> <h4 class="title">Included studies</h4> <p>Of the 11 included studies, seven were randomized controlled trials (RCTs) and four were cross‐over trials (<a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a>; <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>; <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>; <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>). They were published between 1986 and 2019. The nine fully published studies were conducted in Spain (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>), France (<a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>), Austria (<a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>), Portugal (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>), UK (<a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>), Australia (<a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a>; <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>), USA (<a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a>), and Turkey (<a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). One paper was published only as abstracts and was conducted in the UK (<a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>). The <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a> trial was conducted in the UK and published as a letter to the editor. </p> <p>All papers had been published in English language journals. We wrote to all trial authors for further information. We have provided complete details of the 11 included studies in the <a href="./references#CD011711-sec-0168" title="">Characteristics of included studies</a> table. For the cross‐over trials, we reported data from the first treatment arm only. </p> <section id="CD011711-sec-0073"> <h5 class="title">Participants</h5> <p>Eleven studies involving 250 randomized people with neuromuscular disease (NMD) met the inclusion criteria. The trialists excluded 13 participants from data analysis, so 237 participants provided data. The sample size of the included studies varied from 8 to 48 participants. </p> <p>Three trials involved people with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND; <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a>; <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>). In <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>, the mean age in the training group was 57.14 ± 9.3 years and ranged from 41.5 to 72.5 years; in the control group the mean was 56.8 ± 8.7 years (38.3 to 73.4). The training group in <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> had a mean age of 63.1 ± 10.0 years, and the control group had a mean age of 60.1 ± 10.3 years. <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a> did not provide information about the age of participants. </p> <p>Seven trials included young males (including children) with myopathies: Duchenne muscular dystrophy (DMD), limb‐girdle muscular dystrophy, and Becker muscular dystrophy (BMD) (<a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a>; <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>; <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>; <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>; <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>; <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). In <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>, all participants had the onset of DMD between three and five years of age and were free from respiratory tract infections. None of them had: symptoms or signs of inspiratory muscle fatigue (i.e. exertional dyspnoea, orthopnoea, or paradoxic breathing), sleep disturbance, daytime hypersomnolence, morning headache, or episodes of acute respiratory failure requiring endotracheal ventilation. The age in the training group ranged from 10 to 24 years (mean 13.6 ± 4.5 years), and in the control group from 9 to 20 years (mean 14.5 ± 3.8 years). In a second DMD trial, all participants were clinically stable at the time of evaluation, free of any medication, free from respiratory tract infection, and had no history of acute respiratory failure requiring endotracheal ventilation, neither symptoms or signs of inspiratory muscle fatigue (<a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>). The mean age was 14.7 ± 4.5 years in the training group and 12.63 ± 1.8 years in the control group. In <a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a>, all participants attended a center for physically handicapped children and the mean age was 14.2 years (range 7 to 20). The age of participants in <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a> was between 9 and 14 years (mean 11.6 yrs) and they were recruited from two special schools. <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a> included eight participants with mean age 12.3 years (range 8 to 16). In <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>, ages ranged from 10.4 to 23.4 years (mean 15 years). </p> <p><a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a> included outpatient participants with limb‐girdle muscular dystrophy and BMD that had no visible spinal deformities; had no symptoms or signs of cardiomyopathy, heart failure symptoms or physical findings; had no symptoms or signs of inspiratory muscle fatigue, shortness of breath, orthopnoea or dyspnoea during bathing or swimming, short sentences during speech, tachypnoea, paradoxical movement of abdominal or thoracic wall, problems with cough; and free from respiratory tract infections. The mean age of participants was 22.50 ± 7.50 years and 24.27 ± 9.40 years in the training and control groups, respectively. </p> <p>One trial involved participants with a disorder of the neuromuscular junction (myasthenia gravis), the age of participants ranged 33 to 75 years (mean age 64 ± 10 years) (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>). </p> <section id="CD011711-sec-0074"> <h6 class="title">Diagnostic criteria and disease classification</h6> <p>Six of the included studies reported the diagnostic criteria used. Seven trials did not mention the disease classification (<a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a>; <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>; <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>; <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>; <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>; <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). </p> <p><a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> included participants with definite or probable ALS, using the revised El Escorial criteria (<a href="./references#CD011711-bbs2-0037" title="BrooksBR , MillerRG , SwashM , MunsatTL , World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Sclerosis and Other Motor Neuron Disorders2000;1(5):293‐9. ">Brooks 2000</a>). <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> included participants with possible, probable or definite ALS, according to the revised El Escorial criteria. <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> included participants with Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) scores greater than 24/40 (<a href="./references#CD011711-bbs2-0038" title="CedarbaumJM , StamblerN . Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. Journal of Neurological Sciences1997;152(Suppl 1):S1‐9. ">Cedarbaum 1997</a>). In <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a>, participants had mild to moderately severe symptoms of ALS. </p> <p>DMD diagnosis had been confirmed from clinical, enzymatic and muscle biopsy criteria in two DMD studies (<a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>; <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>). <a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a> confirmed the diagnosis of DMD from the typical clinical presentation and features, raised creatine phosphokinase, electromyograms and muscle biopsy. In <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>, the diagnosis of DMD was based on clinical findings and muscle biopsy. In <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>, all participants were wheelchair dependent. In <a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a>, 17 boys were in wheelchairs and one was still ambulant, and in <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>, 16 were in wheelchairs and two were ambulant. In <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>, the neurologist who referred the patients made the diagnosis of muscular dystrophy (limb‐girdle or BMD) using diagnostic criteria defined by <a href="./references#CD011711-bbs2-0050" title="EmeryAE , editor . Diagnostic Criteria for Neuromuscular Disorders. Baarn, The Netherlands: European Neuromuscular Centre, 1994. [ISBN: ISBN 90 261 0719 6, 72 pp] ">Emery 1994</a>. In <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>, 11 of the 30 participants were wheelchair dependent, corresponding to a stage 9 functional capacity, using the criteria of <a href="./references#CD011711-bbs2-0068" title="InkleySR , OldenburgFC , VignosPJJr . Pulmonary function in Duchenne muscular dystrophy related to stage of disease. The American Journal of Medicine1974;56(3):297‐306. ">Inkley 1974</a>. </p> <p><a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a> categorized participants as subclass IIa and IIb according to the myasthenia gravis classification of Osserman and Genkins (<a href="./references#CD011711-bbs2-0083" title="OssermanKE , GenkinsG . Studies in myasthenia gravis: review of a twenty‐year experience in over 1200 patients. The Mount Sinai Journal of Medicine1971;38(6):497‐537. ">Osserman 1971</a>). </p> </section> </section> <section id="CD011711-sec-0075"> <h5 class="title">Interventions and comparisons</h5> <p>Eight studies assessed inspiratory muscle training (IMT); the control groups were sham IMT (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>; <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>), no training (<a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>; <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>; <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>), or breathing exercises (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). In four studies that performed threshold IMT, the training load ranged from 15% to 60% of maximal inspiratory pressure (MIP) (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>; <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>; <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>). The training in one of these trials consisted of 10 minutes of diaphragmatic breathing, 10 minutes of interval‐based IMT and 10 minutes of pursed lip breathing (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>). <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> applied a delayed start design. The IMT group received an active IMT protocol for eight months and the control group received sham IMT for the first four months, followed by an identical active IMT training protocol for the last four months. Thus, we considered data from the first four months for analysis. The frequency of threshold IMT, i.e. the number of days per week dedicated to the RMT program, ranged from three times a week to twice daily for 10 to 15 minutes. The duration of the interventions was between six weeks and four months. Another four trials performed resistive IMT. In <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>, the participants from this trial used an inspirometer device that entailed forced inspiration against a resistance, which increased as inspiratory flow increased to a total of 20 inspirations/day. In one study, the inspiratory resistance was varied to give a subjectively heavy but tolerable load for 10 to 15 minutes (<a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>). The participants in <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a> had to perform both resistive breathing manoeuvres and maximal static inspiratory efforts against the almost occluded resistance. The inspiratory resistive breathing training consisted of 10 loaded breathing cycles of one minute duration each, twice daily. Fifteen minutes after the resistive breathing training, the participants had to perform 10 maximal static inspiratory efforts and reach a certain minimal pressure value. In <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>, to exercise the respiratory muscles, the participants were required to inhale through a mask while playing a video game. The training consisted of 20‐minute sessions, five days a week, with the participants choosing the computer game they wanted to play. Inspiratory effort was increased by their having to breathe through a mask to both start and continue the games. The resistive IMT duration ranged from 18 days to six months. </p> <p>Two trials studied expiratory muscle training (EMT). One trial compared EMT with sham IMT (<a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>). Participants trained with 90% of maximal expiratory pressure (MEP), twice a day, for two months. In <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a>, participants completed eight weeks of training at home, five days a week, with weekly home therapy visits. The trial compared EMT (50% of MEP) to training using a sham device (internal spring removed). </p> <p><a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a> performed a combined RMT (strength training plus endurance training) over two months. For strength training, maximum static inspiratory and expiratory manoeuvres at approximately 20% intervals over the vital capacity (VC) range were performed. The boys trained for about 30 minutes per day. For endurance training, the participants ventilated to exhaustion three times with recovery intervals. The initial resistances selected were those that led to exhaustion within three minutes. When each subject was able to ventilate without exhaustion through a resistance for three minutes or longer, the resistance was increased. In the control group, the participants were not trained. </p> </section> <section id="CD011711-sec-0076"> <h5 class="title">Outcomes</h5> <p>All the included studies assessed our primary outcome, lung capacity, however four studies did not provide data for analysis (<a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a>; <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>; <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>; <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>). Inspiratory muscle strength was measured in 10 trials, but only five studies reported sufficient numerical data and were entered in our analysis (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>; <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>; <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). Seven trials assessed expiratory muscle strength, and we included five in quantitative analysis (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>; <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a>; <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). Physical function in carrying out activities of daily living was reported in two studies. <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> assessed this using the ALS Functional Rating Scale (ALSFRS; <a href="./references#CD011711-bbs2-0038" title="CedarbaumJM , StamblerN . Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. Journal of Neurological Sciences1997;152(Suppl 1):S1‐9. ">Cedarbaum 1997</a>), and <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> used the revised ALSFRS (ALSFRS‐R; <a href="./references#CD011711-bbs2-0039" title="CedarbaumJM , StamblerN , MaltaE , FullerC , ThurmondB , NakanishiA . The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). Journal of the Neurological Sciences1999;169(1‐2):13‐21. ">Cedarbaum 1999</a>). Two trials measured quality of life. <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> assessed this using EuroQol‐5D (<a href="./references#CD011711-bbs2-0093" title="RabinR , deCharroF . EQ‐5D: a measure of health status from the EuroQol Group. Annals of Medicine2001;33(5):337‐43. ">Rabin 2001</a>), and the trial report provided sufficient numerical data. <a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a> evaluated quality of life using the Short Form‐36 Health Survey questionnaire (SF‐36; <a href="./references#CD011711-bbs2-0032" title="AlonsoJ , PrietoL , AntóJM . The Spanish version of the SF‐36 Health Survey (the SF‐36 health questionnaire): an instrument for measuring clinical results [La versión española del SF‐36 Health Survey (Cuestionario de Salud SF‐36): un instrumentopara la medida de los resultados clínicos]. Medicine Clinica1995;104(20):771‐6. ">Alonso 1995</a>), but the data (mean and SD) were reported for three domains (physical role functioning, physical functioning, and emotional role functioning) in the training group and for one domain (bodily pain) in the control groups. Thus, we did not present the data. <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> stated that exercise protocol employed in their study had no adverse effects. Other trials did not provide data on adverse events. None of the included studies evaluated the number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure. </p> </section> </section> <section id="CD011711-sec-0077"> <h4 class="title">Excluded studies</h4> <p>We excluded 18 studies (reported in 19 articles), which are listed in the <a href="./references#CD011711-sec-0169" title="">Characteristics of excluded studies</a> table. We excluded 12 studies that were not RCTs or quasi‐RCTs; five studies because they included participants with more than one type of NMD (myopathies and neuropathies) or more than one type of neurological disorder, or because a participant used non‐invasive ventilation. </p> <section id="CD011711-sec-0078"> <h5 class="title">Ongoing studies</h5> <p>We found one ongoing trial, of respiratory training versus sham training in people with ALS (<a href="./references#CD011711-bbs2-0029" title="NCT02710110 . Respiratory strength training in persons with amyotrophic lateral sclerosis (ALS) [The impact of respiratory strength training in individuals with amyotrophic lateral sclerosis (ALS)]. clinicaltrials.gov/ct2/show/NCT02710110 (first posted 16 March 2016). [NCT02710110] ">NCT02710110</a>). See the <a href="./references#CD011711-sec-0170" title="">Characteristics of ongoing studies</a> table for details. </p> </section> </section> </section> <section id="CD011711-sec-0079"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD011711-fig-0002">Figure 2</a> for an illustration of the review authors' 'Risk of bias' judgements across all studies and the 'Risk of bias' tables (in the <a href="./references#CD011711-sec-0168" title="">Characteristics of included studies</a> table) for further information. </p> <div class="figure" id="CD011711-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study. Red (‐) = high risk of bias; yellow (?) = unclear risk of bias; green (+) = low risk of bias." data-id="CD011711-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p> Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study. Red (‐) = high risk of bias; yellow (?) = unclear risk of bias; green (+) = low risk of bias. </p> </div> </div> </div> <section id="CD011711-sec-0080"> <h4 class="title">Allocation</h4> <p><a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a> allocated participants to either the training or control group alternately, according to the order of their arrival in hospital. We therefore judged this trial to be at a high risk of bias. Three trials were at low risk of bias. <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a> used a computer program to generate the randomization sequence and numbered containers to conceal allocation (this information is from correspondence). <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> randomized the participants in blocks of six, and then used numbered containers to implement the random allocation sequence (we ascertained this information from correspondence). <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> employed a permuted block randomization schedule and concealed the sequence until the intervention was assigned (we ascertained this information from correspondence). Thus, we judged them to be at low risk of bias. The remaining seven trials were at unclear risk of bias, as they did not report the randomization method used. </p> </section> <section id="CD011711-sec-0081"> <h4 class="title">Blinding</h4> <p>Five studies were described as double‐blind (assessors and participants) and we judged them to be at low risk of performance bias and detection bias (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a>; <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>; <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>; <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>). Four trials reported insufficient information about blinding of participants and personnel and we judged the risk of performance bias to be unclear (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>; <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>; <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). However, the outcome assessors were blind to the intervention and we classified these trials as being at low risk of detection bias. <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a> and <a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a> did not mention blinding, so we judged them to have an unclear risk of performance and detection bias. </p> </section> <section id="CD011711-sec-0082"> <h4 class="title">Incomplete outcome data</h4> <p>In two studies, all participants who started the training finished it and had their data included in the analysis (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>; <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>). <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> and <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a> imputed missing data using an appropriate method (intention‐to‐treat analysis). A small number of participants dropped out of four studies, but the reasons for the missing outcome data were unrelated to the intervention (<a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a>; <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). In one trial (<a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>), six of 18 (33%) participants were excluded from analysis, either due to imbalance in numbers or reasons of missing data across intervention groups. We judged <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a> and <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a> to have an unclear risk of attrition bias, as the reports provided no information about exclusions from the analysis. </p> </section> <section id="CD011711-sec-0083"> <h4 class="title">Selective reporting</h4> <p>Two studies reported data for all outcomes (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>). We also considered <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> at low risk of selective reporting bias. The remaining eight studies did not report one or more outcomes appropriately, and we were unable to extract or calculate the mean difference (MD) and standard deviation (SD) for each group separately. Therefore, we judged them to have a high risk of reporting bias. </p> </section> <section id="CD011711-sec-0084"> <h4 class="title">Other potential sources of bias</h4> <p>We considered 'other bias' a category of exclusion, for bias that did not fall into other categories. Where no bias was apparent we considered the risk low. We did not identify other sources of bias in nine studies and judged them as being at low risk of bias for this domain. One was published only as abstract (<a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>), and another as a letter to the editor (<a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>), therefore we judged these to have an unclear risk of other bias. </p> </section> </section> <section id="CD011711-sec-0085"> <h3 class="title" id="CD011711-sec-0085">Effects of interventions</h3> <p>See: <a href="./full#CD011711-tbl-0001"><b>Summary of findings for the main comparison</b> Respiratory muscle training versus sham training in ALS</a>; <a href="./full#CD011711-tbl-0002"><b>Summary of findings 2</b> Respiratory muscle training versus sham training in DMD</a>; <a href="./full#CD011711-tbl-0003"><b>Summary of findings 3</b> Respiratory muscle training versus no training in DMD</a>; <a href="./full#CD011711-tbl-0004"><b>Summary of findings 4</b> Respiratory muscle training versus breathing exercises in limb‐girdle muscular dystrophy or Becker muscular dystrophy</a>; <a href="./full#CD011711-tbl-0005"><b>Summary of findings 5</b> Respiratory muscle training versus breathing exercises in myasthenia gravis</a> </p> <section id="CD011711-sec-0086"> <h4 class="title">Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS) </h4> <p>Three trials compared a form of respiratory muscle training (RMT) with sham training in people with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND; <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>; <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a>; <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>). <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>, <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a> and <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> involved 24, 14 and 48 participants with ALS/MND, respectively. See <a href="./full#CD011711-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>None of the trials of RMT versus sham training in ALS provided long‐term data (at time points greater than 1 year). <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> and <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a> measured short‐term outcomes (at less than 3 months) and <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> provided medium‐term data (between 3 months and 1 year). </p> <section id="CD011711-sec-0087"> <h5 class="title">Primary outcome: measures of lung capacity (e.g. total lung capacity (TLC), forced vital capacity (FVC)) </h5> <section id="CD011711-sec-0088"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a> (N = 14) was published only as an abstract and reported neither numerical nor narrative data for FVC and forced expiratory volume in 1 second (FEV₁). </p> <p><a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> showed no clear difference between the RMT and sham groups with respect to change in the per cent predicted FVC (from baseline to 8 weeks) (mean difference (MD) 0.70, 95% confidence interval (CI) ‐8.48 to 9.88; 1 trial, N = 46; low‐certainty evidence; <a href="./references#CD011711-fig-0003" title="">Analysis 1.1</a>). We graded the certainty of evidence as low, downgrading twice for very serious imprecision as the study was small and the CI was very wide and included the possibility of no effect. </p> </section> <section id="CD011711-sec-0089"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p>In <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>, the mean change in sitting FVC (from baseline to 4 months) favoured inspiratory muscle training (IMT) over sham IMT, but the CI included the possibility of no effect (MD 10.86% of predicted, 95% CI ‐4.25 to 25.97; 1 trial, N = 24; low‐certainty evidence; <a href="./references#CD011711-fig-0004" title="">Analysis 1.2</a>). The minimum clinically important difference (MCID) for FVC in NMDs has not yet been established. However, <a href="./references#CD011711-bbs2-0046" title="du BoisRM , WeyckerD , AlberaC , BradfordWZ , CostabelU , KartashovA , et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. American Journal of Respiratory Critical Care Medicine2011;184(12):1382‐9. ">du Bois 2011</a> estimated the MCID for FVC% in people with idiopathic pulmonary fibrosis, another restrictive respiratory disorder, as 2% to 6%, based on a trial involving 1156 participants. Thus, the effect size in <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> was potentially clinically important, but imprecision limited our confidence in the result. We graded the certainty of evidence as low, downgrading twice for very serious imprecision as the study was small and the CI was very wide and included the possibility of no effect. </p> </section> </section> <section id="CD011711-sec-0090"> <h5 class="title">Inspiratory muscle strength, measured by maximal inspiratory pressure (MIP) and sniff nasal inspiratory pressure (SNIP) </h5> <section id="CD011711-sec-0091"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a> reported neither numerical nor narrative data for this outcome. <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> did not assess this outcome. </p> </section> <section id="CD011711-sec-0092"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p><a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> showed no clear difference in the change in per cent predicted sitting MIP (from baseline to 4 months) between the IMT and sham IMT group (MD ‐8.15%, 95% CI ‐29.85 to 13.54; 1 trial, N = 24; <a href="./references#CD011711-fig-0005" title="">Analysis 1.3</a>), nor was there a clear difference in change in per cent predicted sitting SNIP over the same period (MD ‐10.38%, 95% CI ‐30.44 to 9.67; 1 trial, N = 24; <a href="./references#CD011711-fig-0006" title="">Analysis 1.4</a>). There is no established MCID for evaluating the clinical significance of changes in MIP or SNIP. The sample size was small and the wide CI included no effect; these results were therefore very imprecise. </p> </section> </section> <section id="CD011711-sec-0093"> <h5 class="title">Expiratory muscle strength, measured by maximal expiratory pressure (MEP)</h5> <section id="CD011711-sec-0094"> <h6 class="title">Short term (less than 3 months)</h6> <p>Two ALS studies provided short‐term data on MEP (<a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a>; <a href="./references#CD011711-bbs2-0008" title="SulemanM , WhitelyA , KinnearW . Expiratory muscle training in motor neurone disease [Abstract]. Thorax2003;58(Suppl 3):iii77‐8. ">Suleman 2003</a>). Analysis of pooled data found that MEP was higher with expiratory muscle training (EMT) than sham EMT (MD 20.24, 95% CI 6.58 to 33.90; I² = 0%; 2 trials, N = 60; <a href="./references#CD011711-fig-0007" title="">Analysis 1.5</a>). The sample size was small and was less than the targeted sample size generated by the power calculation. </p> </section> <section id="CD011711-sec-0095"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p><a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> found little or no difference in change in MEP between IMT and sham IMT groups at four months (MD ‐7.62% of predicted, 95% CI ‐32.06 to 16.83; 1 trial, N = 24; <a href="./references#CD011711-fig-0008" title="">Analysis 1.6</a>). The sample size was small and the wide CI included no effect; the results were therefore very imprecise. </p> </section> </section> <section id="CD011711-sec-0096"> <h5 class="title">Physical function in carrying out activities of daily living, measured by a validated instrument </h5> <p>No data were available on physical function in the long term from any trial. <a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> and <a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> provided short‐ and medium‐term data, respectively. </p> <p><b>Short term (less than 3 months)</b> </p> <p><a href="./references#CD011711-bbs2-0004" title="PlowmanE , TaborL , RosadoMK , RobisonR , GazianoJ , RichterJ , et al. A randomized sham control trial of EMST on bulbar function. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2015;16(Suppl 1):44. [DOI: 10.3109/21678421.2015.1089039/0065] PlowmanEK , RosadoM , TaborL , TurnerK , GazianoJ , RichterJ , et al. Impact of expiratory muscle strength training on bulbar function in amyotrophic lateral sclerosis: updates from a randomized sham‐controlled clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2014;15:206. PlowmanEK , Tabor‐GrayL , RosadoKM , VasilopoulosT , RobisonR , ChapinJL , et al. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham‐controlled trial. Muscle &amp; Nerve2019;59(1):40‐6. [DOI: 10.1002/mus.26292] ">Plowman 2019</a> showed no clear difference in the change in Amyotrophic Lateral Sclerosis Functional Rating Scale‐Revised (ALSFRS‐R) score between EMT and sham EMT groups at eight weeks (MD 0.80, 95% CI ‐1.41 to 3.01; 1 trial, N = 46; low‐certainty evidence; <a href="./references#CD011711-fig-0009" title="">Analysis 1.7</a>). The ALSFRS‐R includes 12 questions and each task is rated on a five‐point scale from 0 (cannot do) to 4 (normal ability). Individual item scores are summed to produce a reported score of between 0 (worst) and 48 (best). </p> <p>This result was very imprecise as the study was small and the CI was very wide, and included the possibility of no effect. Additionally, an intervention period of two months may not be adequate to document disease‐related progression or the potential impact of EMT on this outcome, and the trial included participants with ALSFRS‐R score &gt; 30. </p> <section id="CD011711-sec-0097"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p><a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> assessed physical functioning in people with ALS on the ALSFRS (a scale with a range from 0 to 40), and reported the change in score between baseline and four months. There was no clear difference between IMT and sham IMT groups in the mean change in ALSFRS score (MD 0.85, 95% CI ‐2.16 to 3.85; 1 trial, N = 24; low‐certainty evidence; <a href="./references#CD011711-fig-0010" title="">Analysis 1.8</a>). We downgraded the certainty of the evidence to low because of very serious imprecision. The study was small and the CI included potentially clinically relevant effects in either direction. There is no established MCID for the ALSFRS, but as the scale ranges from 0 to 40, we judged less than 1 point to be too small a change to make a difference clinically. </p> </section> </section> <section id="CD011711-sec-0098"> <h5 class="title">Quality of life, measured by a validated questionnaire</h5> <p>Data were not available for this outcome at either short‐ or long‐term time points from the studies of RMT versus sham training. </p> <section id="CD011711-sec-0099"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p><a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> measured quality of life using EuroQol‐5D in 24 people with ALS (<a href="./references#CD011711-bbs2-0093" title="RabinR , deCharroF . EQ‐5D: a measure of health status from the EuroQol Group. Annals of Medicine2001;33(5):337‐43. ">Rabin 2001</a>). In this study, the participants evaluated their overall health status using a VAS (visual analog scale; a vertical scale with end points of 0 and 100). The MD for the change in EuroQol‐5D score between IMT and sham IMT groups after a four‐month intervention was 0.77 (95% CI ‐17.09 to 18.62; 1 trial;, N = 24; low‐certainty evidence; <a href="./references#CD011711-fig-0011" title="">Analysis 1.9</a>). </p> <p>We downgraded the evidence two levels for serious imprecision because the sample size was small and the CI included clinically important effects in either direction. </p> </section> </section> <section id="CD011711-sec-0100"> <h5 class="title">Adverse events</h5> <p><a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a> (N = 24) stated that their exercise protocol had no adverse effect (very low‐certainty evidence). The other ALS trial did not provide information on adverse events. We downgraded the evidence three times for study limitations (reporting bias) and imprecision (small sample size and no events). </p> </section> <section id="CD011711-sec-0101"> <h5 class="title">Other secondary outcomes</h5> <p>No study of RMT versus sham training in people with ALS evaluated the number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure. </p> </section> </section> <section id="CD011711-sec-0102"> <h4 class="title">Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD)</h4> <p>Two trials in people with DMD compared training versus sham training: <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a> (N = 20) and <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a> (N = 16). Both only reported short‐term outcomes (at less than 3 months). See <a href="./full#CD011711-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD011711-sec-0103"> <h5 class="title">Primary outcome: measures of lung capacity (e.g. total lung capacity (TLC), forced vital capacity (FVC)) </h5> <section id="CD011711-sec-0104"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a> found no clear difference between RMT and sham training groups in FVC measured 18 days after the intervention (MD 0.16 L, 95% CI ‐0.31 to 0.63; 1 trial, N = 20; <a href="./references#CD011711-fig-0013" title="">Analysis 2.2</a>) or FEV₁ (MD 0.18 L, 95% CI ‐0.28 to 0.64; 1 trial, N = 20; low‐certainty evidence; <a href="./references#CD011711-fig-0016" title="">Analysis 2.5</a>). </p> <p>In <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>, the mean post‐intervention (6‐week) total lung capacity (TLC) between IMT and sham training groups favoured IMT (MD 0.45 L, 95% CI ‐0.24 to 1.14; 1 trial, N = 16; <a href="./references#CD011711-fig-0012" title="">Analysis 2.1</a>). The mean control TLC was 2.79 L; the MD of 0.45 L represents approximately a 16% difference between the groups. The mean forced residual capacity (FRC) at six weeks also favoured IMT (MD 0.40 L, 95% CI ‐0.12 to 0.92; 1 trial, N = 16; <a href="./references#CD011711-fig-0014" title="">Analysis 2.3</a>). The mean control FRC was 1.47 L; the MD of 0.4 L therefore corresponds to an improvement of 27%. The post‐intervention vital capacity (VC) suggested no clear difference between IMT and sham training groups in VC (MD 0.02 L, 95% CI ‐0.57 to 0.61; 1 trial, N = 16; <a href="./references#CD011711-fig-0015" title="">Analysis 2.4</a>). </p> <p>We downgraded the certainty of evidence for all these outcomes two levels to low certainty for very serious imprecision, as the sample size was small and the CI was wide, including both an important effect and no effect. </p> </section> <section id="CD011711-sec-0105"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p>Neither study measured lung capacity in the medium term.</p> </section> </section> <section id="CD011711-sec-0106"> <h5 class="title">Inspiratory muscle strength, measured by maximal inspiratory pressure (MIP) and sniff nasal inspiratory pressure (SNIP) </h5> <section id="CD011711-sec-0107"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a> assessed MIP at six weeks and <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a> at 18 days. The MD for MIP indicated no clear difference between IMT and sham IMT groups (MD 2.84 cmH₂O, 95% CI ‐1.47 to 7.15; I² = 0%; 2 trials, N = 36; <a href="./references#CD011711-fig-0017" title="">Analysis 2.6</a>). However, in <a href="./references#CD011711-bbs2-0009" title="TopinN , MateckiS , LeBrisS , RivierF , EchenneB , PrefautC , et al. Dose‐dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscular Disorders2002;12(6):576‐83. [PUBMED: 12117483] ">Topin 2002</a>, the training protocol used a low‐intensity IMT specifically designed to improve inspiratory muscle endurance. Since the adaptations to training are specific, inspiratory endurance training would not be sufficient to improve MIP. Indeed, in this study there was no change in MIP, but respiratory muscle endurance showed a considerable increase. <a href="./references#CD011711-bbs2-0005" title="RodilloE , Noble‐JamiesonCM , AberV , HeckmattJZ , MuntoniF , DubowitzV . Respiratory muscle training in Duchenne muscular dystrophy. Archives of Disease in Childhood1989;64(5):736‐8. ">Rodillo 1989</a> performed only 18 days of RMT and this period of training could be too short to improve the MIP. </p> <p>There was very serious imprecision, as the sample size was small, and the CI included no effect. </p> </section> <section id="CD011711-sec-0108"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p>Neither study measured inspiratory muscle strength in the medium term.</p> </section> </section> <section id="CD011711-sec-0109"> <h5 class="title">Other secondary outcomes</h5> <p>Neither trial reported change in inspiratory or expiratory muscle strength, physical function, quality of life, unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure, or adverse events. </p> </section> </section> <section id="CD011711-sec-0110"> <h4 class="title">Respiratory muscle training versus no training in DMD</h4> <p><a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a> (N = 30), <a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a> (N = 17), <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a> (N = 8) and <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a> (N = 12) compared a form of RMT with no training in participants with DMD. <a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a> and <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a> measured short‐term outcomes (at less than 3 months). Two studies measured medium‐term data (between 3 months and 1 year) (<a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a>; <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>). None of these trials provided long‐term data (at time points greater than 1 year). <a href="./full#CD011711-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD011711-sec-0111"> <h5 class="title">Primary outcome: measures of lung capacity (e.g. total lung capacity (TLC), forced vital capacity (FVC)) over the short term </h5> <section id="CD011711-sec-0112"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a> and <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a>, which were cross‐over studies, did not provide data for each study period, therefore, the outcomes could not be meta‐analysed. </p> </section> <section id="CD011711-sec-0113"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p><a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a> assessed VC and FEV₁ in young males with DMD who underwent training or no training. Post‐intervention (6‐month) VC values showed no clear difference between groups, whether expressed as absolute values (MD 0.14 L, 95% CI ‐0.44 to 0.72; 1 trial, N = 30; <a href="./references#CD011711-fig-0018" title="">Analysis 3.1</a>) or as per cent predicted (MD 3.50%, 95% CI ‐14.35 to 21.35; 1 trial, N = 30; <a href="./references#CD011711-fig-0019" title="">Analysis 3.2</a>). For FEV₁, the final value (after a 6‐month intervention) increased slightly in the training group compared to the no training group (MD 0.18 L, 95% CI ‐0.29 to 0.65; 1 trial, N = 30; low‐certainty evidence; <a href="./references#CD011711-fig-0020" title="">Analysis 3.3</a>). There is no established MCID for FEV₁ in NMDs. Changes greater than 12% and 0.2 L in the FEV₁ may be clinically important (<a href="./references#CD011711-bbs2-0087" title="PellegrinoR , ViegiG , BrusascoV , CrapoRO , BurgosF , CasaburiR , et al. Interpretative strategies for lung function tests. European Respiratory Journal2005;26(5):948‐68. ">Pellegrino 2005</a>). In people with chronic obstructive pulmonary disease (COPD), a 100 mL improvement in FEV₁ was associated with reduction of 5.9 units in St. George's Respiratory Questionnaire (SGRQ; <a href="./references#CD011711-bbs2-0069" title="JonesPW , QuirkFH , BaveystockCM . The St George's Respiratory Questionnaire. Respiratory Medicine1991;85(suppl B):25‐31. [DOI: http://dx.doi.org/10.1016/S0954‐6111(06)80166‐6] ">Jones 1991</a>; <a href="./references#CD011711-bbs2-0070" title="JonesPW , QuirkFH , BaveystockCM , LittlejohnsP . A self‐complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. American Review of Respiratory Disease1992;145(6):1321‐7. ">Jones 1992</a>; <a href="./references#CD011711-bbs2-0072" title="JonesPW . St. George’s Respiratory Questionnaire: MCID. COPD2005;2(1):75‐9. ">Jones 2005</a>), a disease‐specific instrument designed to measure impact on overall health, daily life, and perceived well‐being in patients with obstructive airways disease (<a href="./references#CD011711-bbs2-0044" title="de laLogeC , TugautB , FofanaF , LambertJ , HennigM , TschiesnerU , et al. Relationship between FEV1 and patient‐reported outcomes changes: results of a meta‐analysis of randomized trials in stable COPD. Chronic Obstructive Pulmonary Disease2016;3(2):519‐38. ">de la Loge 2016</a>). A mean change of 4 units on the SGRQ is associated with slightly efficacious treatment (<a href="./references#CD011711-bbs2-0071" title="JonesPW . Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal2002;19(3):398‐404. ">Jones 2002</a>). However, the use of MCIDs from studies of chronic respiratory diseases in NMDs has significant limitations. </p> <p>We downgraded the certainty of evidence two levels to low for very serious imprecision as the sample size was small and CIs were wide). </p> <p><a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a> was a cross‐over study that did not provide individual data for the six‐month time point. </p> </section> </section> <section id="CD011711-sec-0114"> <h5 class="title">Inspiratory muscle strength, measured by maximal inspiratory pressure (MIP) and sniff nasal inspiratory pressure (SNIP) </h5> <section id="CD011711-sec-0115"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a> and <a href="./references#CD011711-bbs2-0006" title="SmithPE , CoakleyJH , EdwardsRH . Respiratory muscle training in Duchenne muscular dystrophy. Muscle &amp; Nerve1988;11(7):784‐7. ">Smith 1988</a> did not provide data for each study period, therefore, we could not assess the results. </p> </section> <section id="CD011711-sec-0116"> <h6 class="title">Medium term (greater than 3 months but less than 1 year)</h6> <p>In <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a>, the maximal sniff assessed esophageal pressure (Pesmax) and maximal transdiaphragmatic pressure (Pdimax) values served as outcome measures for global inspiratory muscle strength and diaphragmatic strength, respectively. These measures were obtained in 30 participants with DMD; however, eight people (5 in the training group and 3 in the control group) had VC values less than 25% of those predicted and/or a partial pressure of carbon dioxide in the arterial blood (PaCO₂) of more than 45 mmHg, indicating severe pulmonary function impairment. We did not consider data from these eight participants for analysis. The final values (at 6 months) demonstrated an improvement in Pesmax (MD 22.53 cmH₂O, 95% CI 13.33 to 31.73; 1 trial, N = 22; <a href="./references#CD011711-fig-0021" title="">Analysis 3.4</a>) and Pdimax (MD 24.39 cmH₂O, 95% CI 14.65 to 34.13; 1 trial, N = 22; <a href="./references#CD011711-fig-0022" title="">Analysis 3.5</a>) in the IMT group in comparison to the no training group. </p> <p>These outcomes were subject to serious imprecision, as the sample size was small and CI wide. </p> <p><a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a> did not provide individual data for the six‐month time point. </p> </section> </section> <section id="CD011711-sec-0117"> <h5 class="title">Expiratory muscle strength, measured by maximal expiratory pressure (MEP)</h5> <section id="CD011711-sec-0118"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0002" title="MartinAJ , SternL , YeatesJ , LeppD , LittleJ . Respiratory muscle training in Duchenne muscular dystrophy. Developmental Medicine &amp; Child Neurology1986;28(3):314‐8. ">Martin 1986</a> and <a href="./references#CD011711-bbs2-0007" title="SternLM , MartinAJ , JonesN , GarrettR , YeatesJ . Training inspiratory resistance in Duchenne dystrophy using adapted computer games. Developmental Medicine &amp; Child Neurology1993;31(4):494‐500. ">Stern 1989</a> reported neither numerical nor narrative data from the first treatment arm. </p> </section> </section> <section id="CD011711-sec-0119"> <h5 class="title">Other secondary outcomes</h5> <p>No study of respiratory training versus no training evaluated the following secondary outcomes: change in physical function in carrying out activities of daily living, quality of life, number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure, and adverse events. </p> </section> </section> <section id="CD011711-sec-0120"> <h4 class="title">Respiratory muscle training versus breathing exercises in limb‐girdle muscular dystrophy or Becker muscular dystrophy (BMD) </h4> <p><a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a> involved 21 participants with limb‐girdle muscular dystrophy and BMD, and reported results after 12 weeks of IMT or breathing exercises. The trial did not report medium‐term or long‐term outcomes. </p> <section id="CD011711-sec-0121"> <h5 class="title">Primary outcome: measures of lung capacity (e.g. total lung capacity (TLC), forced vital capacity (FVC)) </h5> <section id="CD011711-sec-0122"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a> provided numerical data for the change from baseline in each intervention group. The MD showed no clear difference between the IMT and breathing exercises group for FVC (MD 0.01 L, 95% CI ‐0.11 to 0.13; N = 21; <a href="./references#CD011711-fig-0023" title="">Analysis 4.1</a>), VC (MD ‐0.02 L, 95% CI ‐0.15 to 0.11; N = 21; <a href="./references#CD011711-fig-0024" title="">Analysis 4.2</a>) or FEV₁ (MD 0.03 L, 95% CI ‐0.09 to 0.15; N = 21; <a href="./references#CD011711-fig-0025" title="">Analysis 4.3</a>). There was very serious imprecision in the analysis as the sample size was small and CIs were wide. Additionally, the trial was at high risk of selection bias. </p> </section> </section> <section id="CD011711-sec-0123"> <h5 class="title">Inspiratory muscle strength, measured by maximal inspiratory pressure (MIP) and sniff nasal inspiratory pressure (SNIP) </h5> <section id="CD011711-sec-0124"> <h6 class="title">Short term (less than 3 months)</h6> <p>In <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>, 12 weeks of IMT improved MIP in comparison to breathing exercises (MD 18.50 cmH₂O, 95% CI 1.29 to 35.71; N = 21; <a href="./references#CD011711-fig-0026" title="">Analysis 4.4</a>). The sample size was small and the result very imprecise. The trial was at high risk of selection bias. </p> </section> </section> <section id="CD011711-sec-0125"> <h5 class="title">Expiratory muscle strength, measured by maximal expiratory pressure (MEP)</h5> <section id="CD011711-sec-0126"> <h6 class="title">Short term (less than 3 months)</h6> <p>In <a href="./references#CD011711-bbs2-0011" title="YeldanI , GursesHN , YukselH . Comparison study of chest physiotherapy home training programmes on respiratory functions in patients with muscular dystrophy. Clinical Rehabilitation2008;22(8):741‐8. [PUBMED: 18678574] ">Yeldan 2008</a>, 12 weeks of RMT in people with muscular dystrophies produced no clear improvement in MEP in comparison to breathing exercises (MD ‐2.47 cmH₂O, 95% CI ‐13.82 to 8.88; N = 21; <a href="./references#CD011711-fig-0027" title="">Analysis 4.5</a>). The sample size was small and the result very imprecise. The trial was at high risk of selection bias. </p> </section> </section> <section id="CD011711-sec-0127"> <h5 class="title">Other secondary outcomes</h5> <p>The following secondary outcomes were not evaluated: quality of life, physical function in carrying out activities of daily living, number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure, adverse events. </p> </section> </section> <section id="CD011711-sec-0128"> <h4 class="title">Respiratory muscle training (RMT) versus breathing exercises in myasthenia gravis</h4> <p><a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a> (N = 27) compared a form of RMT with breathing exercises in people with myasthenia gravis and reported only short‐term outcomes (after 8 weeks of RMT). See <a href="./full#CD011711-tbl-0005">summary of findings Table 5</a>. </p> <section id="CD011711-sec-0129"> <h5 class="title">Primary outcome: measures of lung capacity (e.g. total lung capacity (TLC), forced vital capacity (FVC)) </h5> <section id="CD011711-sec-0130"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a> reported numerical data as mean and standard deviation (SD) for each evaluation period. The final values from <a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a> showed no clear difference between the RMT group and the breathing exercises group in TLC (MD ‐0.20 L, 95% CI ‐1.07 to 0.67; N = 27; <a href="./references#CD011711-fig-0028" title="">Analysis 5.1</a>), FVC (‐0.20 L, 95% CI ‐0.80 to 0.40; N = 27; <a href="./references#CD011711-fig-0029" title="">Analysis 5.2</a>), residual volume (RV) (MD 0.00 L, 95% CI ‐0.30 to 0.30; N = 27; <a href="./references#CD011711-fig-0030" title="">Analysis 5.3</a>), inspiratory capacity (IC) (MD ‐0.10 L, 95% CI ‐0.63 to 0.43; N = 27; <a href="./references#CD011711-fig-0031" title="">Analysis 5.4</a>), or FEV₁ (MD ‐0.30 L, 95% CI ‐0.90 to 0.30; N = 27; <a href="./references#CD011711-fig-0032" title="">Analysis 5.5</a>). We downgraded the evidence for all of these outcomes two levels to low certainty for very serious imprecision as the sample size was small and the CIs wide. </p> </section> </section> <section id="CD011711-sec-0131"> <h5 class="title">Inspiratory muscle strength, measured by maximal inspiratory pressure (MIP) and sniff nasal inspiratory pressure (SNIP) </h5> <section id="CD011711-sec-0132"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a> did not provide sufficient numerical data on MIP (only final values were reported in graphs) and we were unable to calculate MD and SD. The trial authors reported narratively that eight weeks of RMT in people with myasthenia gravis increased MIP in comparison to the control group. </p> </section> </section> <section id="CD011711-sec-0133"> <h5 class="title">Expiratory muscle strength, measured by maximal expiratory pressure (MEP)</h5> <section id="CD011711-sec-0134"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a> provided mean MEP and SD for each intervention group. We calculated the change from baseline and obtained the SD from P values for differences in means. The results showed that eight weeks' RMT improved MEP in comparison to breathing exercises in people with myasthenia gravis (MD 15.00 cmH₂O, 95% CI 4.45 to 25.55; N = 27; <a href="./references#CD011711-fig-0033" title="">Analysis 5.6</a>). The data were imprecise, the sample size small, and the risk of bias from randomization, allocation concealment and blinding of participants was unclear. The trial protocol was not directly targeted to expiratory muscles; however, the training group performed diaphragmatic breathing, followed interval‐based IMT and performed pursed lip breathing. The authors of this trial suggest that pursed lip breathing could have influenced the functional improvement of expiratory muscles in the control group. </p> </section> </section> <section id="CD011711-sec-0135"> <h5 class="title">Quality of life, measured by a validated questionnaire</h5> <section id="CD011711-sec-0136"> <h6 class="title">Short term (less than 3 months)</h6> <p><a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a> assessed quality of life using the SF‐36 Health Survey questionnaire (<a href="./references#CD011711-bbs2-0032" title="AlonsoJ , PrietoL , AntóJM . The Spanish version of the SF‐36 Health Survey (the SF‐36 health questionnaire): an instrument for measuring clinical results [La versión española del SF‐36 Health Survey (Cuestionario de Salud SF‐36): un instrumentopara la medida de los resultados clínicos]. Medicine Clinica1995;104(20):771‐6. ">Alonso 1995</a>), but the data (mean and SD) were reported for three domains (physical role functioning, physical functioning and emotional role functioning) in the training group and for one domain (bodily pain) in the control groups. Thus, we did not present the data. </p> <p>The trial authors reported narratively that, in people with myasthenia gravis, a change in one of the nine SF‐36 domains (physical role functioning) showed an improvement in the RMT group compared to the breathing exercises group (N = 27; very low‐certainty evidence). We downgraded the evidence twice for serious imprecision and once for study limitations. </p> </section> </section> <section id="CD011711-sec-0137"> <h5 class="title">Other secondary outcomes</h5> <p>The following secondary outcomes were not evaluated: physical function in carrying out activities of daily living, number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure and adverse events. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011711-sec-0138" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011711-sec-0138">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011711-sec-0203">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011711-sec-0138"></div> <section id="CD011711-sec-0139"> <h3 class="title" id="CD011711-sec-0139">Summary of main results</h3> <p>We assessed the effects of respiratory muscle training (RMT) (inspiratory muscle training (IMT) or expiratory muscle training (EMT), or both) for neuromuscular disease (NMD) in children and adults. Eleven studies satisfied the inclusion criteria. These studies included 250 randomized participants (237 evaluable) with myopathies (Duchenne muscular dystrophy (DMD; 6 studies), limb‐girdle muscular dystrophy or Becker muscular dystrophy (BMD; 1 study), amyotrophic lateral sclerosis (ALS; 3 studies), and myasthenia gravis (1 study). Eight trials investigated the effects of IMT, two studied EMT, and a single trial investigated IMT plus EMT. RMT was compared with sham training, no training, or breathing exercises. Heterogeneity in interventions, populations, comparators and outcome measures meant that no meta‐analysis was possible for most comparisons. </p> <section id="CD011711-sec-0140"> <h4 class="title">Measures of lung capacity</h4> <p>All included studies assessed lung capacity, our primary outcome. In people with ALS, IMT may lead to some benefit over sham IMT, based on the change in the per cent predicted forced vital capacity (FVC) from baseline to four months in one study. Another trial in ALS showed no clear difference in the change in per cent predicted FVC (from baseline to 8 weeks) between participants treated with EMT compared to those treated with sham EMT. </p> <p>Four studies performed in people with myopathies reported data on lung capacity. In the short term, RMT may produce a small improvement in TLC (6 weeks) in young males with DMD, but may lead to no effect on FVC (18 days) in boys with DMD when compared to sham RMT. Moreover, RMT may lead to no clear difference in the per cent predicted vital capacity (VC%) in comparison to no training (at 6 months follow‐up), or FVC in comparison to breathing exercises (at 12 weeks follow‐up), respectively. </p> <p>In people with myasthenia gravis, based on a single trial, RMT may lead to little difference in TLC (at 8 weeks follow‐up) in comparison to respiratory exercises. </p> <p>The remaining four trials (1 in ALS and 3 in myopathies) did not provide data on lung capacity. </p> </section> <section id="CD011711-sec-0141"> <h4 class="title">Inspiratory muscle strength</h4> <p>In people with ALS, the effect of IMT on the change in inspiratory muscle strength between baseline and four months may result in little difference from sham IMT. </p> <p>In people with DMD, RMT may improve inspiratory muscle strength in comparison to no training in the medium term (6 months); but when compared to sham training, in the short term, may lead to no clear difference between groups, based on two studies with six weeks and 18 days of training. In comparison to breathing exercises, it is uncertain whether RMT improves inspiratory muscle strength in people with myopathies, because the certainty of the evidence is very low. </p> </section> <section id="CD011711-sec-0142"> <h4 class="title">Expiratory muscle strength</h4> <p>In ALS, there was a higher expiratory muscle strength with EMT when compared to sham EMT in the short term. However, IMT may lead to no effect on expiratory muscle strength in the medium term (4 months) in people with ALS/MND. </p> <p>The effects of RMT in comparison to breathing exercises in the short term (12 weeks) in people with limb‐girdle muscular dystrophy and BMD are unclear because the certainty of evidence is very low. </p> <p>In myasthenia gravis, IMT may improve expiratory muscle strength post‐8 weeks in comparison to breathing exercises. </p> </section> <section id="CD011711-sec-0143"> <h4 class="title">Physical functioning</h4> <p>Two trials assessed physical functioning in people with ALS; one in the short term (8 weeks) and another in the medium term (4 months). Both trials showed that there may be no clinically meaningful difference in ALSFRS between IMT and sham IMT groups. </p> </section> <section id="CD011711-sec-0144"> <h4 class="title">Quality of life</h4> <p>In relation to quality of life, four months of IMT may lead to no clear difference in EuroQol‐5D in comparison to sham IMT in participants with ALS. </p> <p>A trial that assessed quality of life in people with myasthenia gravis using the SF‐36 reported an improvement in one of the nine SF‐36 domains (physical role functioning) in the IMT group compared to the breathing exercises group after eight weeks. </p> </section> <section id="CD011711-sec-0145"> <h4 class="title">Adverse events</h4> <p>One trial involving people with ALS compared IMT to sham IMT and stated that their exercise protocol had no adverse effect. Due to very low‐certainty evidence it is uncertain whether IMT may have adverse effects in this group. Other trials did not provide data on adverse events. </p> <p>No included study provided long‐term data (at time points greater than 1 year) or evaluated the number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure. </p> </section> </section> <section id="CD011711-sec-0146"> <h3 class="title" id="CD011711-sec-0146">Overall completeness and applicability of evidence</h3> <p>The effect of RMT in people with NMDs has long been controversial.</p> <p>The trials included participants with DMD, limb‐girdle muscular dystrophy, BMD, ALS/MND, and myasthenia gravis. The results may not be generalized to other NMDs. The small number of trials did not allow for meaningful subgroup analyses. Thus we did not investigate the effects of RMT by age of the participants (children versus adults). Children are not little adults and these groups are pathophysiologically distinct (<a href="./references#CD011711-bbs2-0073" title="LandriganPJ , GargA . Children are not little adults. In: Pronczuk‐GarbinoJ editor(s). Children's Health and the Environment: a global perspective: a resource manual for the health sector. Geneva: World Health Organization, 2005:3‐16. ">Landrigan 2005</a>). Thus, children may have different responses to therapies in comparison to adults. Moreover, the power of a study to detect a real difference between interventions depends on sample size. Very small samples undermine the internal and external validity of a trial, while very large samples tend to transform small differences into statistically significant differences, even when they are clinically insignificant (<a href="./references#CD011711-bbs2-0054" title="FaberJ , FonsecaLM . How sample size influences research outcomes. Dental Press Journal of Orthodontics2014;19(4):27‐9. ">Faber 2014</a>). The CONSORT (Consolidated Standards of Reporting Trials) statement recommends that the clinical trials should indicate how the sample size was determined (<a href="./references#CD011711-bbs2-0040" title="MoherD , HopewellS , SchulzKF , MontoriV , GøtzschePC , DevereauxPJ , et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology2010;63(8):834‐40. ">CONSORT 2010</a>). However, no study included in this review reported how sample size was determined. </p> <p>For RMT benefits to be achieved, the principles of exercise prescription must be considered to ensure an adequate RMT 'dose'. The prescription of the RMT program should ideally be reported according to the so‐called FITT components (<b>F</b> requency, <b>I</b> ntensity, <b>T</b> ime and <b>T</b>ype of exercise) (<a href="./references#CD011711-bbs2-0100" title="RiebeD . Exercise prescription. In: PescatelloLS editor(s). ACSM's Guidelines for Exercise Testing and Prescription. 9th Edition. Philadelphia: Wolters Kluwer/Lippincott Williams &amp; Wilkins Health, 2014:161‐93. ">Riebe 2014</a>). However, the ideal FITT components for RMT for people with NMD are uncertain. In the majority of the included studies in this systematic review, interventions were performed once or twice per day, for five to seven days per week. The RMT programs involved low‐to‐high intensity exercise and the duration of interventions ranged from six weeks to seven months. Our findings are based mainly on pressure threshold IMT and cannot be extrapolated to any other type of training. </p> <p>In addition to dose‐dependent effects of IMT, impaired ventilatory function may alter the effects of RMT on inspiratory muscle strength. In participants whose respiratory system involvement is slowly progressive, i.e. in whom VC declined by less than 10% in the year before the start of training, there was a significant positive correlation between the number of successfully completed IMT programs and improvement in maximal inspiratory pressure (MIP). In people whose VC decline is more rapidly progressive (more than 10%), no significant correlation between the improvement of MIP and the intensity of training was found (<a href="./references#CD011711-bbs2-0115" title="WinklerG , ZifkoU , NaderA , FrankW , ZwickH , ToiflK , et al. Dose‐dependent effects of inspiratory muscle training in neuromuscular disorders. Muscle &amp; Nerve2000;23(8):1257‐60. ">Winkler 2000</a>). Moreover, <a href="./references#CD011711-bbs2-0010" title="MerkleM , WankeTH , FormanekD , LahrmannH , ToiflK , ZwickH . Inspiratory muscle training in patients with neuromuscular disease [abstract]. European Respiratory Journal1993;6(Suppl 17):310S. UngarD , GösslerR , ToiflK , WankeT . Innovative respiratory muscle training for patients with Duchenne muscular dystrophy‐a psychological evaluation. Wiener Medizinische Wochenschrift1996;146(9‐10):213‐6. [PUBMED: 9012219] WankeT , ToiflK , MerkleM , FormanekD , LahrmannH , ZwickH . Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest1994;105(2):475‐82. [PUBMED: 8306750] WildM , WankeT , LahrmannH , MerkleM , ToiflK , ZwickH . Training of the respiratory musculature in muscle dystrophy Duchenne. Atemwegs ‐ und Lungenkrankheiten1995;21:478. ">Wanke 1994</a> showed that in people with VC &lt; 25% of predicted and/or PaCO<sub>2</sub> &gt; 45 mmHg, inspiratory muscle function had not improved with IMT. </p> <p>Most included studies in our review compared a form of RMT with a control group using sham training. No trial included in this review compared different intensities of RMT (e.g. low versus high intensity) or different types of RMT (e.g. IMT versus IMT plus EMT). </p> <p>Five (71%), two (29%) and four (57%) of our seven prespecified outcomes were addressed in the analysis comparing RMT with sham training, no training and breathing exercises, respectively. Moreover, the data were not always presented in a suitable format. We had planned to develop the analysis using the change from baseline measures, but some trials reported only final values. Thus when the change from baseline was not reported, we extracted final values and both final values and change from baseline were reported and would have been used in any meta‐analysis. The number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure was not measured or reported in any of the included studies. Only one study reported whether participants experienced adverse events (<a href="./references#CD011711-bbs2-0003" title="PintoS , DeCarvalhoM . Respiratory exercises in amyotrophic lateral sclerosis (reals). Amyotrophic Lateral Sclerosis2009;10:59. [EMBASE: 70078384] PintoS , SwashM , deCarvalhoM . Respiratory exercise in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2012;13(1):33‐43. [PUBMED: 22214352] PintoS , deCarvalhoM . Can inspiratory muscle training increase survival in early‐affected amyotrophic lateral sclerosis patients?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2013;14(2):124‐6. [PUBMED: 23035780] ">Pinto 2012</a>). </p> <p>Nitric oxide is a potent regulator of skeletal muscle metabolism, mass, function and regeneration. In DMD, there is loss of neuronal nitric oxide synthase and the capacity of the muscles for endogenous nitric oxide synthesis (<a href="./references#CD011711-bbs2-0108" title="TimpaniCA , HayesA , RybalkaE . Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy. Orphanet Journal of Rare Diseases2017;12:100. [DOI: 10.1186/s13023‐017‐0652‐y] ">Timpani 2017</a>). During exercise, people with DMD do not increase blood flow in the working muscles by attenuating sympathetic (i.e. α‐adrenergic) vasoconstriction. This impairment of the protective mechanism results in functional muscle ischemia due to unopposed sympathetic vasoconstriction (<a href="./references#CD011711-bbs2-0107" title="ThomasGD . Functional muscle ischemia in Duchenne and Becker muscular dystrophy. Frontiers in Physiology2013;4:381. [DOI: 10.3389/fphys.2013.00381] ">Thomas 2013</a>). Therefore, we have concerns about ischemic muscle damage in this subgroup of patients with NMD during RMT due to the absence of high‐certainty evidence on RMT in people with DMD. </p> <section id="CD011711-sec-0147"> <h4 class="title">Certainty of the evidence</h4> <p>Eleven studies met the inclusion criteria. These trials involved 250 randomized people with NMD, and data from 237 participants was included in the quantitative analysis. Therefore, there was a sample size loss of only 5.2%. </p> <p>All but two of the included studies were at high risk of bias in at least one domain, and many reported insufficient information for accurate assessment of the risk of bias. The major methodological limitations were lack of information about random sequence generation and allocation concealment, lack of blinding (particularly with subjective outcomes highly susceptible to biased assessment), and selective outcome reporting. Trials rarely described the methods used to assign participants to groups or for concealment of allocation (<a href="./references#CD011711-bbs2-0105" title="SavovićJ , JonesH , AltmanD , HarrisR , JűniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies. Health Technology Assessment2012;16(35):1–82. ">Savović 2012</a>). Three included trials had a proper sequence generation and allocation concealment. In studies in which sequence generation and allocation concealment are inadequate or unclear (versus adequate), intervention effect estimates have been found to be exaggerated by approximately 7% and 10%, respectively (<a href="./references#CD011711-bbs2-0084" title="PageMJ , HigginsJP , ClaytonG , SterneJA , HróbjartssonA , SavovićJ . Empirical evidence of study design biases in randomized trials: systematic review of meta‐epidemiological studies. PLoS One2016;11(7):e0159267. ">Page 2016</a>). Moreover, our analyses relied on subjective outcomes, which appear to be at greater risk of bias than objective outcomes (<a href="./references#CD011711-bbs2-0084" title="PageMJ , HigginsJP , ClaytonG , SterneJA , HróbjartssonA , SavovićJ . Empirical evidence of study design biases in randomized trials: systematic review of meta‐epidemiological studies. PLoS One2016;11(7):e0159267. ">Page 2016</a>). Eight included trials were judged to be at high risk of reporting bias. We experienced some difficulties in entering the data of studies into our analysis because some numerical data were not reported and other results were not always presented in a suitable format (e.g. values reported only in graphs). The CONSORT (Consolidated Standards of Reporting Trials) statement recommends that, for each outcome, trial data should be reported as a summary of the outcome in each group together with the effect size, which for continuous data is usually the difference in means and standard deviation for the difference (<a href="./references#CD011711-bbs2-0040" title="MoherD , HopewellS , SchulzKF , MontoriV , GøtzschePC , DevereauxPJ , et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Journal of Clinical Epidemiology2010;63(8):834‐40. ">CONSORT 2010</a>). </p> <p>The certainty of evidence across the different outcomes was low to very low. For all outcomes, imprecision of results contributed to a downgrading when we applied GRADE criteria (<a href="./references#CD011711-bbs2-0106" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html. ">Schünemann 2013</a>). Most findings in our review came from single studies with small numbers of participants, i.e. the sample size of trials included in the analysis varied from 14 to 48 participants. Moreover there is a wide CI around the estimate of the effect, including both an important effect and no effect. Although there were methodological limitations, we judged all but two of the included studies to have no serious limitations and we did not downgrade them. </p> <p>Participants, interventions, and outcomes were not substantially different from those considered in the question in this systematic review. In addition, we have no reason to suspect publication bias, since the search strategy found studies with a small sample and 'negative studies', i.e. trials reporting statistically insignificant findings. </p> <p>Taking into account the small number of participants included, differences in the training protocols and the imprecision in most of the analyses limit our confidence in the results. Moreover, data from the trials were not always presented in a suitable format for meta‐analysis. Thus, any conclusions must be drawn very cautiously. New, high quality evidence is likely to have had an important impact on our confidence in the estimates of effect for the outcomes investigated and potentially could affect our assessment of the effects of interventions of this type. </p> </section> </section> <section id="CD011711-sec-0148"> <h3 class="title" id="CD011711-sec-0148">Potential biases in the review process</h3> <p>Dr Fregonezi was not involved in assessment of his own study for inclusion or bias, nor did he assist in the extraction and analysis of the data (<a href="./references#CD011711-bbs2-0001" title="FregoneziGA , GuellR , PradasJ , CasanP . Effects of inspiratory muscle training program in generalized myasthenia gravis. European Respiratory Journal2003;22(Suppl 45):2729. FregoneziGA , ResquetiVR , GüellR , PradasJ , CasanP . Effects of 8‐week, interval‐based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest2005;128(3):1524‐30. [PUBMED: 16162753] ">Fregonezi 2005</a>). </p> <p>NMDs are generally fairly rare in single centers, thus some studies have included a heterogeneous sample with different NMD in order to gain sufficient power. However, diseases affecting the anterior horn cells, peripheral nerves, and/or muscles would not respond in the same way to exercise training (<a href="./references#CD011711-bbs2-0031" title="AbreschRT , CarterGT , HanJJ , McDonaldCM . Exercise in neuromuscular diseases. Physical Medicine Rehabilitation Clinics North America2012;23(3):653‐73. ">Abresch 2012</a>). As the pathophysiology of each NMD is different, we considered that the effects of RMT might differ between different types of NMD. Therefore, we excluded trials in which participants had a variety of NMDs since we could not obtain results for each condition separately. Because of this, when studies with different types of NMDs were included in the same comparison, we entered study data into a forest plot for visual interpretation of the results but did not pool them. These approaches may introduce bias in this review. </p> <p>We had difficulty performing and interpreting the comparisons due to substantial differences between the studies, including the populations, FITT components and data presentation (for example, absolute and predicted values). In order to minimise heterogeneity between studies, we performed three comparisons according to the control group (sham training, no training, and breathing exercises). Accordingly there were a few studies for each comparison in the meta‐analysis. Therefore, we were unable to undertake the proposed subgroup and sensitivity analyses. If we had been able to include more studies in our meta‐analysis, we might have demonstrated possible differences between different types of NMD (myopathies, disorders of the neuromuscular junction, and neuropathies) and differences related to the duration of the interventions. Moreover, sensitivity analysis could have identified the influence of some factors (such as random sequence generation and allocation concealment) on the results, thus revealing a more accurate estimate of the effect of the interventions. </p> <p>Some studies did not report methodology in sufficient detail. We tried to minimise possible biases by contacting the authors to verify study characteristics and to request data, but some authors had no data available, while others did not respond to our emails. Furthermore, despite our attempts to apply a systematic process in assessment of the risk of bias, the final decisions are necessarily subject to a level of interpretation. Methods have not been substantially modified from the protocol (<a href="./references#CD011711-bbs2-0118" title="PedrosaR , SilvaIS , AzevedoIG , ForbesA‐M , FregoneziGA , Dourado JuniorME , et al. Respiratory muscle training in children and adults with neuromuscular disease. Cochrane Database of Systematic Reviews2015, Issue 5. [DOI: 10.1002/14651858.CD011711] ">Pedrosa 2015</a>). We have reported any deviations in <a href="#CD011711-sec-0166">Differences between protocol and review</a>. </p> </section> <section id="CD011711-sec-0149"> <h3 class="title" id="CD011711-sec-0149">Agreements and disagreements with other studies or reviews</h3> <p>We identified three systematic reviews that evaluated the effects of RMT in people with neuromuscular and neurological conditions generally. </p> <p><a href="./references#CD011711-bbs2-0048" title="EidenbergerM , NowotnyS . Inspiratory muscle training in patients with amyotrophic lateral sclerosis: a systematic review. NeuroRehabilitation2014;35(3):349‐61. ">Eidenberger 2014</a> reviewed the efficacy of IMT in ALS, and found four studies: two RCTs, one pre‐experimental study and one with a historical control group. The authors concluded that there was limited evidence that IMT induces strengthening of inspiratory muscles in participants with ALS. Moreover, in the <a href="./references#CD011711-bbs2-0048" title="EidenbergerM , NowotnyS . Inspiratory muscle training in patients with amyotrophic lateral sclerosis: a systematic review. NeuroRehabilitation2014;35(3):349‐61. ">Eidenberger 2014</a> review no statistical analysis was performed. </p> <p><a href="./references#CD011711-bbs2-0055" title="FerreiraGD , CostaAC , PlentzRD , CoronelCC , SbruzziG . Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta‐analysis. Physiotherapy2016;102(3):221‐8. ">Ferreira 2016</a> reviewed nine RCTs and observed that RMT significantly increased respiratory muscle strength and FEV₁ in people with multiple sclerosis and ALS. </p> <p>Recently, <a href="./references#CD011711-bbs2-0066" title="HumanA , CortenL , JelsmaJ , MorrowB . Inspiratory muscle training for children and adolescents with neuromuscular diseases: A systematic review. Neuromuscular Disorders2017;27(6):503‐17. ">Human 2017</a> systematically reviewed the effects of RMT with an external device compared to control group. The population was children aged between 5 and 18 years with NMDs. The authors identified seven studies, all but one of which we also included in our review. We excluded the seventh trial included in <a href="./references#CD011711-bbs2-0066" title="HumanA , CortenL , JelsmaJ , MorrowB . Inspiratory muscle training for children and adolescents with neuromuscular diseases: A systematic review. Neuromuscular Disorders2017;27(6):503‐17. ">Human 2017</a> because the trial report did not provide separate data for different types of NMD (spinal muscular atrophy and DMD) (<a href="./references#CD011711-bbs2-0018" title="GozalD , ThirietP . Respiratory muscle training in neuromuscular disease: long‐term effects on strength and load perception. Medicine &amp; Science in Sports &amp; Exercise1999;31(11):1522‐7. ">Gozal 1999</a>). Six of these studies showed no significant improvement in pulmonary function tests after IMT. Moreover, two trials reported significant increases in inspiratory muscle endurance and four studies found significantly greater improvement in inspiratory muscle strength in the training groups. The review concluded that in the population under review, although RMT might benefit respiratory muscle strength and endurance, evidence was lacking for other outcomes and adverse events, and there was no clear evidence for or against its use. </p> <p>Our analysis (7 RCTs and 4 cross‐over trials providing data) showed that RMT may improve lung capacity and respiratory muscle strength in some NMDs. To our knowledge, this is the first systematic review that has included participants with disorders of the neuromuscular junction (myasthenia gravis). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011711-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011711-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study. Red (‐) = high risk of bias; yellow (?) = unclear risk of bias; green (+) = low risk of bias." data-id="CD011711-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p> Risk of bias summary: review authors' judgements about each 'Risk of bias' item for each included study. Red (‐) = high risk of bias; yellow (?) = unclear risk of bias; green (+) = low risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 1 Change in FVC (% of predicted): short term." data-id="CD011711-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 1 Change in FVC (% of predicted): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 2 Change in FVC (% of predicted): medium term." data-id="CD011711-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 2 Change in FVC (% of predicted): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 3 Change in MIP (% of predicted): medium term." data-id="CD011711-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 3 Change in MIP (% of predicted): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 4 Change in SNIP (% of predicted): medium term." data-id="CD011711-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 4 Change in SNIP (% of predicted): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 5 MEP (cmH₂O): short term." data-id="CD011711-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 5 MEP (cmH₂O): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 6 Change in MEP (% of predicted): medium term." data-id="CD011711-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 6 Change in MEP (% of predicted): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 7 Change in ALSFRS‐R: short term." data-id="CD011711-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 7 Change in ALSFRS‐R: short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 8 Change in ALSFRS: medium term." data-id="CD011711-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 8 Change in ALSFRS: medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 9 Change in EuroQol‐5D: medium term." data-id="CD011711-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS), Outcome 9 Change in EuroQol‐5D: medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 1 Post‐intervention TLC (L): short term." data-id="CD011711-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 1 Post‐intervention TLC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 2 Post‐intervention FVC (L): short term." data-id="CD011711-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 2 Post‐intervention FVC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 3 Post‐intervention FRC (L): short term." data-id="CD011711-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 3 Post‐intervention FRC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 4 Post‐intervention VC (L): short term." data-id="CD011711-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 4 Post‐intervention VC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 5 Post‐intervention FEV₁ (L): short term." data-id="CD011711-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 5 Post‐intervention FEV₁ (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 6 MIP (cmH₂O): short term." data-id="CD011711-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD), Outcome 6 MIP (cmH₂O): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 1 Post‐intervention VC (L): medium term." data-id="CD011711-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 1 Post‐intervention VC (L): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 2 Post‐intervention VC (% of predicted): medium term." data-id="CD011711-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 2 Post‐intervention VC (% of predicted): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 3 Post‐intervention FEV₁ (L): medium term." data-id="CD011711-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 3 Post‐intervention FEV₁ (L): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 4 Post‐intervention Pesmax (cmH₂O): medium term." data-id="CD011711-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 4 Post‐intervention Pesmax (cmH₂O): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 5 Post‐intervention Pdimax (cmH₂O): medium term." data-id="CD011711-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD), Outcome 5 Post‐intervention Pdimax (cmH₂O): medium term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 1 FVC (L): short term." data-id="CD011711-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 1 FVC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 2 Change in VC (L): short term." data-id="CD011711-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 2 Change in VC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 3 Change in FEV₁ (L): short term." data-id="CD011711-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 3 Change in FEV₁ (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 4 Change in MIP (cmH₂O): short term." data-id="CD011711-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 4 Change in MIP (cmH₂O): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 5 Change in MEP (cmH₂O): short term." data-id="CD011711-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle), Outcome 5 Change in MEP (cmH₂O): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 1 Post‐intervention TLC (L): short term." data-id="CD011711-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 1 Post‐intervention TLC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 2 FVC (L): short term." data-id="CD011711-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 2 FVC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 3 Post‐intervention RV (L): short term." data-id="CD011711-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 3 Post‐intervention RV (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 4 Post‐intervention IC (L): short term." data-id="CD011711-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 4 Post‐intervention IC (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 5 FEV₁ (L): short term." data-id="CD011711-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 5 FEV₁ (L): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011711-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/urn:x-wiley:14651858:media:CD011711:CD011711-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_t/tCD011711-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 6 Change in MEP (cmH₂O): short term." data-id="CD011711-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Respiratory muscle training versus breathing exercises in myasthenia gravis, Outcome 6 Change in MEP (cmH₂O): short term. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/media/CDSR/CD011711/image_n/nCD011711-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011711-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Respiratory muscle training versus sham training in ALS</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Respiratory muscle training compared to sham training in ALS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with ALS<br/> <b>Intervention:</b> respiratory muscle training<br/> <b>Comparison:</b> sham training </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with sham training</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with respiratory muscle training</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> <p>(change from baseline in % predicted FVC)<br/> Follow‐up: 8 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in % predicted FVC in the control group was ‐8.3%</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in % predicted FVC in the training group was 0.70% less of a decline than in the sham training group (8.48 more of a decline to 9.88 less of a decline) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> (change from baseline in % predicted FVC)<br/> Follow‐up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in % predicted FVC in the control group was ‐5.20%<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in % predicted FVC in the training group was 10.86% less of a decline than in the sham training group<br/> (4.25 more of a decline to 25.97 less of a decline) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RMT may improve lung capacity in comparison to sham training in the medium term</p> <p>The MCID for FVC, based on estimations in idiopathic pulmonary fibrosis is 2% to 6% (<a href="./references#CD011711-bbs2-0046" title="du BoisRM , WeyckerD , AlberaC , BradfordWZ , CostabelU , KartashovA , et al. Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. American Journal of Respiratory Critical Care Medicine2011;184(12):1382‐9. ">du Bois 2011</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function in carrying out activities of daily living</b> over the medium term (3 to 12 months; change from baseline)<br/> Assessed with: ALSFRS (maximum possible total score 40)<br/> Follow‐up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The estimated mean change in the control group was ‐3.80<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in physical function assessed with ALSFRS was</p> <p>0.85 points less of a decline than in the sham training group (2.16 more of a decline to 3.85 less of a decline) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There may be no clinically meaningful difference in ALSFRS score between training and sham training groups in the medium term. </p> <p>Higher scores on the ALSFRS indicate better physical functioning.</p> <p>There is no established MCID for ALSFRS, but as the scale ranges from 0 to 40, we judged less than 1 point to be too small to make a difference. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> (change from baseline) in the medium term<br/> Assessed with: EuroQol‐5D, a 0 to 100 point visual analogue scale. The bottom rate (0) corresponds to " the worst health you can imagine", and the highest rate (100) corresponds to "the best health you can imagine"<br/> Follow‐up: 4 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in the control group was not available</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in quality of life score in the training group was MD 0.77 less of a decline<br/> (17.09 more of a decline to 18.62 less of a decline) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There may be no clinically important difference in EuroQol score between the training and sham training groups in the medium term. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>One 4‐month trial of IMT in 24 people with ALS reported that no adverse event occurred.</p> <p>A second ALS trial, in 14 participants with ALS, did not provide information on adverse events. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The certainty of the available evidence on RMT in ALS was too low for conclusions to be drawn about adverse events. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>ALS:</b> amyotrophic lateral sclerosis; <b>ALSFRS:</b> Amyotrophic Lateral Sclerosis Functional Rating Scale; <b>CI:</b> confidence interval; <b>FEV₁:</b> forced expiratory volume in one second; <b>FVC:</b> forced vital capacity; <b>IMT:</b> inspiratory muscle training; <b>MCID:</b> minimum clinically important difference; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial; <b>RMT</b>: respiratory muscle training </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The control group data were obtained from graphical representation of some outcomes, which included all participants who completed the study period (N = 9). Another study (N = 14) measured FVC and FEV₁ in the short term but was only published as an abstract and provided no data.<br/> <sup>b</sup>We downgraded the evidence twice for serious imprecision due to small sample size and because the CIs included both an important effect and no effect.<br/> <sup>c</sup>We downgraded the evidence three times: once because this outcome was at high risk of bias due to reporting bias, and twice for serious imprecision due to small sample and low event rate (no events). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Respiratory muscle training versus sham training in ALS</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011711-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Respiratory muscle training versus sham training in DMD</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Respiratory muscle training compared to sham training in DMD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children and young males with DMD<br/> <b>Intervention:</b> respiratory muscle training<br/> <b>Comparison:</b> sham training </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with sham training<sup>a</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with respiratory muscle training</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> <p>Measured by: post‐intervention TLC<br/> Follow‐up: 6 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention TLC in the sham training group was 2.79 L</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention TLC was 0.45 L higher than in the sham training group<br/> (0.24 lower to 1.14 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RMT may slightly increase TLC in comparison to sham training. For this study, a difference of 0.45 L represents approximately a 16% difference from the control group. </p> <p>A second trial did not report TLC but found no clear difference in FVC between RMT and sham training groups after 18 days (MD 0.16 L, 95% CI ‐0.31 to 0.63; N = 20). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function in carrying out activities of daily living</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of unscheduled hospitalizations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two trials with 16 and 20 participants with DMD did not provide information on adverse events </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DMD:</b> Duchenne muscular dystrophy; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial; <b>TLC:</b> total lung capacity </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>The control group data were obtained from graphical representation of some outcomes, which included all participants who completed the study period (N = 9).<br/> <sup>b</sup>We downgraded the evidence twice for serious imprecision due to a small sample size and because CIs included both an important effect and no effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Respiratory muscle training versus sham training in DMD</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011711-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Respiratory muscle training versus no training in DMD</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Respiratory muscle training compared to no training in DMD</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children and young males with DMD<br/> <b>Intervention:</b> respiratory muscle training<br/> <b>Comparison:</b> no training </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with no training</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with respiratory muscle training</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Three cross‐over trials measured short‐term outcomes but did not provide data for each study period. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> </p> <p>Measured by: post‐intervention % predicted VC<br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention % predicted VC was 44.4%</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention % predicted VC was 3.50% higher than in the no training group<br/> (14.35% lower to 21.35% higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/> (1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There may be no clear difference in % predicted VC with RMT in comparison to no training.</p> <p>For more lung capacity outcomes, see text.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function in carrying out activities of daily living</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of unscheduled hospitalizations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>DMD:</b> Duchenne muscular dystrophy; <b>MD:</b> mean difference; <b>RCT:</b> randomized controlled trial; <b>VC:</b> vital capacity </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the evidence twice for serious imprecision due to small sample size and the CIs included both an important effect and no effect. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Respiratory muscle training versus no training in DMD</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011711-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in limb‐girdle muscular dystrophy or Becker muscular dystrophy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with limb‐girdle muscular dystrophy or Becker muscular dystrophy </p> <p><b>Intervention:</b> respiratory muscle training </p> <p><b>Comparison:</b> breathing exercises </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with breathing exercises</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RMT</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> <p>Measured as change from baseline in FVC (L)</p> <p>follow‐up: 12 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in FVC in the breathing exercises group was 0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>FVC decreased on average 0.01 L more (0.11 less to 0.13 more) in the RMT group than the breathing exercises group. (The mean change in FVC in the RMT group was a decrease of 0.01 L) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 (1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The effect of RMT on FVC, when compared to breathing exercises, is uncertain</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Physical function in carrying out activities of daily living</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of unscheduled hospitalisations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>All adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>FVC</b> : forced vital capacity; <b>RCT</b> : randomized controlled trial; <b>RMT</b>: respiratory muscle training </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the certainty of evidence for this outcome to very low, downgrading two levels for very serious imprecision as the sample size was very small and because the CI included both an important effect and no effect, and once for study limitations as the trial was quasi‐randomized (alternate allocation). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in limb‐girdle muscular dystrophy or Becker muscular dystrophy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011711-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in myasthenia gravis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Respiratory muscle training compared to breathing exercises in myasthenia gravis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with myasthenia gravis<br/> <b>Intervention:</b> respiratory muscle training<br/> <b>Comparison:</b> breathing exercises </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with breathing exercises</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk or value with respiratory muscle training</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Measures of lung capacity over the short term (less than 3 months)</b> </p> <p>Measured by: post‐intervention TLC<br/> Follow‐up: 8 weeks </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention TLC was 4.7 L</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean post‐intervention TLC was 0.20 lower than in the breathing exercises group<br/> (‐1.07 lower to 0.67 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> Low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RMT, compared to breathing exercises, may have no clear effect on lung capacity.</p> <p>For other lung capacity outcomes, see text.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the medium term (greater than 3 months but less than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Measures of lung capacity over the long term (greater than 1 year)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Physical function in carrying out activities of daily living</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>The trial authors reported narratively that a change in one of the nine SF‐36 domains (physical role functioning) showed a improvement in the training group compared to the breathing exercises group </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> Very low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether RMT has an effect on quality of life in comparison to breathing exercises </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of unscheduled hospitalizations for episodes of chest infection or acute exacerbation of chronic respiratory failure within 1 year of randomization</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomized controlled trial; <b>RMT</b> : respiratory muscle training; <b>SF‐36:</b> 36‐Item Short Form Health Survey; <b>TLC:</b> total lung capacity </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty</b> : we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate certainty</b> : we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low certainty</b> : our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low certainty</b>: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>We downgraded the evidence three times: once because the trials providing data for this outcome were at high risk of bias, and twice for serious imprecision due to small sample size and the CIs included both an important effect and no effect.<br/> <sup>b</sup>We downgraded the evidence three times: twice because this outcome was at high risk of bias due to reporting bias, and once for serious imprecision due to the small sample. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in myasthenia gravis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/full#CD011711-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011711-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Change in FVC (% of predicted): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in FVC (% of predicted): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in MIP (% of predicted): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in SNIP (% of predicted): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 MEP (cmH₂O): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.24 [6.58, 33.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in MEP (% of predicted): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Change in ALSFRS‐R: short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Change in ALSFRS: medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Change in EuroQol‐5D: medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Respiratory muscle training versus sham training in amyotrophic lateral sclerosis (ALS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011711-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Post‐intervention TLC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Post‐intervention FVC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Post‐intervention FRC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Post‐intervention VC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Post‐intervention FEV₁ (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 MIP (cmH₂O): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.84 [‐1.47, 7.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Respiratory muscle training versus sham training in Duchenne muscular dystrophy (DMD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011711-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Post‐intervention VC (L): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Post‐intervention VC (% of predicted): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Post‐intervention FEV₁ (L): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Post‐intervention Pesmax (cmH₂O): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Post‐intervention Pdimax (cmH₂O): medium term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Respiratory muscle training versus no training in Duchenne muscular dystrophy (DMD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011711-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 FVC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in VC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Change in FEV₁ (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in MIP (cmH₂O): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Change in MEP (cmH₂O): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in muscular dystrophies (Becker and limb‐girdle)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011711-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in myasthenia gravis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Post‐intervention TLC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 FVC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Post‐intervention RV (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Post‐intervention IC (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 FEV₁ (L): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Change in MEP (cmH₂O): short term <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Respiratory muscle training versus breathing exercises in myasthenia gravis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011711.pub2/references#CD011711-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011711.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011711-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011711-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011711-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011711-note-0008">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD011711-note-0009">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD011711-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011711-note-0017">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD011711-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011711-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011711-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011711\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011711\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011711\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011711\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011711\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011711.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011711.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011711.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011711.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011711.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718556254"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011711.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718556258"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011711.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd3395d0af401',t:'MTc0MDcxODU1Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 